<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Thalidomide</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Thalidomide">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Thalidomide</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Thalidomide</b>, sold under the brand name <b>Thalomid</b> among others, is a medication used to treat a number of cancers including multiple myeloma, graft-versus-host disease, and a number of skin conditions including complications of leprosy.<span class="mw-ref" id="cite_ref-AHFS2019_3-0"><a href="#cite_note-AHFS2019-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> While it has been used in a number of HIV associated conditions, such use is associated with increased levels of the virus.<span class="mw-ref" id="cite_ref-AHFS2019_3-1"><a href="#cite_note-AHFS2019-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2019_3-2"><a href="#cite_note-AHFS2019-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>




<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Thalidomide</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Thalidomide_enantiomers.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Thalidomide_enantiomers.svg.png" data-file-width="512" data-file-height="591" data-file-type="drawing" height="231" width="200"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>θ</span><span>ə</span><span>ˈ</span><span>l</span><span>ɪ</span><span>d</span><span>ə</span><span>m</span><span>aɪ</span><span>d</span></span>/</span></span><span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Contergan, Thalomid, Talidex, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>α-Phthalimidoglutarimide</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/thalidomide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/thalidomide.html'" tppabs="https://www.drugs.com/monograph/thalidomide.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a699032.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a699032.html'" tppabs="https://medlineplus.gov/druginfo/meds/a699032.html" class="external text external">a699032</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Thalidomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Thalidomide'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Thalidomide" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Thalidomide&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Thalidomide&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Thalidomide&SearchType=BasicSearch" class="external text external">Thalidomide</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>X (High risk)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>X (Contraindicated)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth (capsules)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>L04AX02<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=L04AX02  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=L04AX02'" tppabs="https://www.whocc.no/atc_ddd_index/?code=L04AX02" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>90%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>55% and 66% for the (<i>R</i>)-(+)- and (<i>S</i>)-(−)-enantiomers, respectively<span class="mw-ref" id="cite_ref-clinp_2-0"><a href="#cite_note-clinp-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (minimally via CYP2C19-mediated 5-hydroxylation; mostly via non-enzymatic hydrolysis at the four amide sites)<span class="mw-ref" id="cite_ref-clinp_2-1"><a href="#cite_note-clinp-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>5–7.5 hours (dose-dependent)<span class="mw-ref" id="cite_ref-clinp_2-2"><a href="#cite_note-clinp-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine, faeces<span class="mw-ref" id="cite_ref-clinp_2-3"><a href="#cite_note-clinp-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1<i>H</i>-isoindole-1,3-dione</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=50-35-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=50-35-1'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=50-35-1" class="external text external">50-35-1</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5426  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5426'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5426" class="external text external">5426</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7327  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7327'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7327" class="external text external">7327</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01041  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01041'" tppabs="https://www.drugbank.ca/drugs/DB01041" class="external text external">DB01041</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.5233.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.5233.html'" tppabs="http://www.chemspider.com/Chemical-Structure.5233.html" class="external text external">5233</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=4Z8R6ORS6L  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=4Z8R6ORS6L'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=4Z8R6ORS6L" class="external text external">4Z8R6ORS6L</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00754  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00754'" tppabs="https://www.kegg.jp/entry/D00754" class="external text external">D00754</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9513  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9513'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9513" class="external text external">CHEBI:9513</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL468  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL468'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL468" class="external text external">ChEMBL468</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID9022524  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID9022524'" tppabs="https://comptox.epa.gov/dashboard/DTXSID9022524" class="external text external">DTXSID9022524</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.000.029  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.000.029'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.000.029" class="external text external">100.000.029</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>13</sub><span>H</span><sub>10</sub><span>N</span><sub>2</sub><span>O</span><sub>4</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">258.233</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28N1C2CCC%28NC2%3DO%29%3DO%29C3%3DCC%3DCC%3DC3C1%3DO  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28N1C2CCC%28NC2%3DO%29%3DO%29C3%3DCC%3DCC%3DC3C1%3DO'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28N1C2CCC%28NC2%3DO%29%3DO%29C3%3DCC%3DCC%3DC3C1%3DO" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Chirality</th><td>Racemic mixture</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(N1C2CCC(NC2=O)=O)C3=CC=CC=C3C1=O</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:UEJJHQNACJXSKW-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=420478187&page2=Thalidomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=420478187&page2=Thalidomide'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=420478187&page2=Thalidomide" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


<p>Common side effects include sleepiness, rash, and dizziness.<span class="mw-ref" id="cite_ref-AHFS2019_3-3"><a href="#cite_note-AHFS2019-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Severe side effects include tumor lysis syndrome, blood clots, and peripheral neuropathy.<span class="mw-ref" id="cite_ref-BNF76_4-0"><a href="#cite_note-BNF76-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Use in pregnancy may harm the baby, including resulting in malformation of the limbs.<span class="mw-ref" id="cite_ref-AHFS2019_3-4"><a href="#cite_note-AHFS2019-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> In males who are taking the medication, condoms are recommended if their partner could become pregnant.<span class="mw-ref" id="cite_ref-BNF76_4-1"><a href="#cite_note-BNF76-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is an immunomodulatory medication and works by a number of mechanisms including stimulating T cells and decreasing TNF-α production.<span class="mw-ref" id="cite_ref-AHFS2019_3-5"><a href="#cite_note-AHFS2019-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


<p>Thalidomide was first marketed in 1957 in West Germany, where it was available over the counter.<span class="mw-ref" id="cite_ref-OUP2003_5-0"><a href="#cite_note-OUP2003-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-Mill1991_6-0"><a href="#cite_note-Mill1991-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> When first released, thalidomide was promoted for anxiety, trouble sleeping, "tension", and morning sickness.<span class="mw-ref" id="cite_ref-Mill1991_6-1"><a href="#cite_note-Mill1991-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Lou2004_7-0"><a href="#cite_note-Lou2004-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> While initially deemed to be safe in pregnancy, concerns regarding birth defects were noted in 1961 and the medication was removed from the market in Europe that year.<span class="mw-ref" id="cite_ref-Mill1991_6-2"><a href="#cite_note-Mill1991-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-OUP2003_5-1"><a href="#cite_note-OUP2003-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> The total number of people affected by use during pregnancy is estimated at 10,000, of which about 40% died around the time of birth.<span class="mw-ref" id="cite_ref-Mill1991_6-3"><a href="#cite_note-Mill1991-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-AHFS2019_3-6"><a href="#cite_note-AHFS2019-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Those who survived had limb, eye, urinary tract, and heart problems.<span class="mw-ref" id="cite_ref-OUP2003_5-2"><a href="#cite_note-OUP2003-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Its initial entry into the US market was prevented by Frances Kelsey at the FDA.<span class="mw-ref" id="cite_ref-Lou2004_7-1"><a href="#cite_note-Lou2004-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> The birth defects of thalidomide led to the development of greater drug regulation and monitoring in many countries.<span class="mw-ref" id="cite_ref-Lou2004_7-2"><a href="#cite_note-Lou2004-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-OUP2003_5-3"><a href="#cite_note-OUP2003-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


<p>It was approved for medical use in the United States in 1998.<span class="mw-ref" id="cite_ref-AHFS2019_3-7"><a href="#cite_note-AHFS2019-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.<span class="mw-ref" id="cite_ref-WHO21st_8-0"><a href="#cite_note-WHO21st-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-BNF76_4-2"><a href="#cite_note-BNF76-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> In the United Kingdom it costs the NHS about £1,194 per month as of 2018.<span class="mw-ref" id="cite_ref-BNF76_4-3"><a href="#cite_note-BNF76-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> This amount in the United States costs about US$9,236 as of 2019.<span class="mw-ref" id="cite_ref-Price2019_9-0"><a href="#cite_note-Price2019-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Pack_of_Thalidomide_tablets.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Pack_of_Thalidomide_tablets.jpg" data-file-width="3088" data-file-height="2056" data-file-type="bitmap" height="146" width="220"><div class="thumbcaption" style="text-align: left">Pack of thalidomide capsules</div></div></div>

<p>Thalidomide is used as a first-line treatment in multiple myeloma in combination with <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">dexamethasone</a> or with <a href="Melphalan.htm" tppabs="https://ptable.com/wiki/compounds/A/Melphalan" title="Melphalan">melphalan</a> and <a href="Prednisone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisone" title="Prednisone">prednisone</a>, to treat acute episodes of erythema nodosum leprosum, and for maintenance therapy.<span class="mw-ref" id="cite_ref-UKlabel2017_10-0"><a href="#cite_note-UKlabel2017-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-USlabel2017_11-0"><a href="#cite_note-USlabel2017-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>The bacterium that causes tuberculosis (TB) is related to leprosy. Thalidomide may be helpful in some cases where standard TB drugs and corticosteroids are not sufficient to resolve severe inflammation in the brain.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>It is used as a second-line treatment to manage graft versus host disease and aphthous stomatitis in children and has been prescribed for other conditions in children including actinic prurigo and epidermolysis bullosa; the evidence for these uses is weak.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span>  It is recommended only as a third line treatment in graft-versus-host-disease in adults, based on lack of efficacy and side effects observed in clinical trials.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Thalidomide should not be used by people who are breastfeeding or pregnant, trying or able to conceive a child, or cannot or will not follow the risk management program to prevent pregnancies. The prescribing doctor is required to ensure that contraception is being used, and regular pregnancy tests are taken. Those allergic to thalidomide should not take it. It should be used with caution in people with chronic infections like HIV or hepatitis B.<span class="mw-ref" id="cite_ref-USlabel2017_11-1"><a href="#cite_note-USlabel2017-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-UKlabel2017_10-1"><a href="#cite_note-UKlabel2017-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    

<p>Thalidomide causes birth defects.<span class="mw-ref" id="cite_ref-USlabel2017_11-2"><a href="#cite_note-USlabel2017-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-UKlabel2017_10-2"><a href="#cite_note-UKlabel2017-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-toxmech2009_17-0"><a href="#cite_note-toxmech2009-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> The U.S. Food and Drug Administration (FDA) and other regulatory agencies have approved marketing of the drug only with an auditable risk evaluation and mitigation strategy that ensures that people using the drug are aware of the risks and avoid pregnancy; this applies to both men and women, as the drug can be transmitted in semen.<span class="mw-ref" id="cite_ref-toxmech2009_17-1"><a href="#cite_note-toxmech2009-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<p>There is a high risk that thalidomide can cause excessive blood clots. There is also a high risk that thalidomide can interfere with formation of various kinds of new blood cells, creating a risk of infection via neutropenia, leukopenia, and lymphopenia, and risks that blood will not clot via thrombocytopenia. There is also a risk of anemia via lack of red blood cells.  The drug can also damage nerves, causing peripheral neuropathy that may be irreversible.<span class="mw-ref" id="cite_ref-USlabel2017_11-3"><a href="#cite_note-USlabel2017-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-UKlabel2017_10-3"><a href="#cite_note-UKlabel2017-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>Thalidomide has several cardiovascular adverse effects, including risk of heart attacks, pulmonary hypertension, and changes in heart rhythm including syncope, bradycardia, and atrioventricular block.<span class="mw-ref" id="cite_ref-USlabel2017_11-4"><a href="#cite_note-USlabel2017-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-UKlabel2017_10-4"><a href="#cite_note-UKlabel2017-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>It can cause liver damage and severe skin reactions like Stevens–Johnson syndrome. It tends to make people sleepy, which creates risk when driving and operating other machinery. As it kills cancer cells, it can cause tumor lysis syndrome. Thalidomide can prevent menstruation.<span class="mw-ref" id="cite_ref-USlabel2017_11-5"><a href="#cite_note-USlabel2017-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-UKlabel2017_10-5"><a href="#cite_note-UKlabel2017-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>Other than the above, very common (reported in more than 10% of people) adverse effects include tremor, dizziness, tingling, numbness, constipation, and peripheral edema.<span class="mw-ref" id="cite_ref-USlabel2017_11-6"><a href="#cite_note-USlabel2017-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-UKlabel2017_10-6"><a href="#cite_note-UKlabel2017-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>

<p>Common adverse effects (reported by 1–10% of people) include confusion, depressed mood, reduced coordination, heart failure, difficulty breathing, interstitial lung disease, lung inflammation, vomiting, dry mouth, rashes, dry skin, fever, weakness, and a sense of unwellness.<span class="mw-ref" id="cite_ref-USlabel2017_11-7"><a href="#cite_note-USlabel2017-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-UKlabel2017_10-7"><a href="#cite_note-UKlabel2017-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Interactions">Interactions</h3></summary>
    
<p>There are no expected pharmacokinetic interactions between thalidomide and other medicines due to its neutral effects on P-glycoprotein and the cytochrome P450 family.  It may interact with sedatives due to its sedative action and bradycardic agents, like beta-blockers, due to its bradycardia-inducing effects. The risk of peripheral neuropathy may be increased by concomitant treatment with other agents known to cause peripheral neuropathy.<span class="mw-ref" id="cite_ref-TGA_18-0"><a href="#cite_note-TGA-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> The risk of venous thromboembolisms with thalidomide seems to be increased when patients are treated with oral contraceptives or other cytotoxic agents (including <a href="Doxorubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxorubicin" title="Doxorubicin">doxorubicin</a> and <a href="Melphalan.htm" tppabs="https://ptable.com/wiki/compounds/A/Melphalan" title="Melphalan">melphalan</a>) concurrently. Thalidomide may interfere with various contraceptives, and hence it is advised that women of reproductive age use at least two different means of contraception to ensure that no child will be conceived while they are taking thalidomide.<span class="mw-ref" id="cite_ref-TGA_18-1"><a href="#cite_note-TGA-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-USlabel2017_11-8"><a href="#cite_note-USlabel2017-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-UKlabel2017_10-8"><a href="#cite_note-UKlabel2017-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Overdose">Overdose</h3></summary>
    
<p>As of 2013, eighteen cases of overdoses had been reported with doses of up to 14.4<span>&nbsp;</span>grams, none of them fatal.<span class="mw-ref" id="cite_ref-TGA_18-2"><a href="#cite_note-TGA-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> No specific antidote for overdose exists and treatment is purely supportive.<span class="mw-ref" id="cite_ref-TGA_18-3"><a href="#cite_note-TGA-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    
<p>The precise mechanism of action for thalidomide is not known, although efforts to identify thalidomide's teratogenic action generated 2,000 research papers and the proposal of 15 or 16 plausible mechanisms by the year 2000.<span class="mw-ref" id="cite_ref-Stephens2000_19-0"><a href="#cite_note-Stephens2000-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> As of 2015, the main theories were inhibition of the process of angiogenesis, its inhibition of cereblon, a ubiquitin ligase, and its ability to generate reactive oxygen species which in turn kills cells.<span class="mw-ref" id="cite_ref-Vargesson2015_20-0"><a href="#cite_note-Vargesson2015-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-Kim2011_21-0"><a href="#cite_note-Kim2011-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> In 2018, results were first published which suggested that thalidomide's teratogenic effects are mediated through degradation of the transcription factor, SALL4, an as yet unverified finding.<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>Thalidomide also binds to and acts as an antagonist of the androgen receptor (AR) and hence is a nonsteroidal antiandrogen (NSAA) of some capacity.<span class="mw-ref" id="cite_ref-LiuSu2010_23-0"><a href="#cite_note-LiuSu2010-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> In accordance, it can produce gynecomastia and sexual dysfunction as side effects in men.<span class="mw-ref" id="cite_ref-NuttallWarrier2015_24-0"><a href="#cite_note-NuttallWarrier2015-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>

<p>Thalidomide is provided as a racemic mixture of two enantiomers; while there are reports that only one of the enantiomers may cause birth defects, the body converts each enantiomer into the other through mechanisms that are not well understood.<span class="mw-ref" id="cite_ref-toxmech2009_17-2"><a href="#cite_note-toxmech2009-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:302px"><img src="../I/m/Thalidomide-structures.png" tppabs="https://ptable.com/wiki/compounds/I/m/Thalidomide-structures.png" data-file-width="1100" data-file-height="594" data-file-type="bitmap" height="162" width="300"><div class="thumbcaption" style="text-align: left">The two enantiomers of thalidomide:<br>Left: (<i>S</i>)-(−)-thalidomide<br>Right: (<i>R</i>)-(+)-thalidomide</div></div></div>

<p>Thalidomide is racemic; while R-thalidomide is the bioactive form of the molecule, the individual enantiomers can racemize to each other due to the acidic hydrogen at the chiral centre, which is the carbon of the <a href="Glutarimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glutarimide" title="Glutarimide">glutarimide</a> ring bonded to the <a href="Phthalimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Phthalimide" title="Phthalimide">phthalimide</a> substituent. The racemization process can occur <i>in vivo</i>.<span class="mw-ref" id="cite_ref-clinp_2-4"><a href="#cite_note-clinp-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-stereospecific44_25-0"><a href="#cite_note-stereospecific44-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-pmid14505639_26-0"><a href="#cite_note-pmid14505639-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-Bartlett2004_27-0"><a href="#cite_note-Bartlett2004-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>

<p>Celgene Corporation originally synthesized thalidomide using a three-step sequence starting with L-glutamic acid treatment, but this has since been reformed by the use of <a href="Glutamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Glutamine" title="Glutamine">L-glutamine</a>.<span class="mw-ref" id="cite_ref-synth_28-0"><a href="#cite_note-synth-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> As shown in the image below, N-carbethoxyphtalimide (1) can react with L-glutamine to yield N-phthaloyl-L-glutamine (2). Cyclization of N-phthaloyl-L-glutamine occurs using <a href="Carbonyldiimidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbonyldiimidazole" title="Carbonyldiimidazole">carbonyldiimidazole</a>, which then yields thalidomide (3).<span class="mw-ref" id="cite_ref-synth_28-1"><a href="#cite_note-synth-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> Celgene Corporation's original method resulted in a 31% yield of S-thalidomide, whereas the two-step synthesis yields 85–93% product that is 99% pure.</p>

<center><div class="thumb tnone"></div><div class="thumbinner" style="width:569px"><img src="../I/m/Thalidomide_syntehsis.png" tppabs="https://ptable.com/wiki/compounds/I/m/Thalidomide_syntehsis.png" data-file-width="1843" data-file-height="402" data-file-type="bitmap" height="124" width="567"><div class="thumbcaption" style="text-align: left">Muller et al.'s two-step thalidomide synthesis</div></div></center>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Thalidomide was discovered by the German pharmaceutical company Chemie Grünenthal (now Grünenthal GmbH) circa 1953. The company had been established as a soap maker after World War II ended, to address the urgent market need for antibiotics. Heinrich Mueckter<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> was appointed to head the discovery program based on his experience working with the German army's antiviral research. While preparing reagents for the work, Mueckter's assistant Wilhelm Kunz isolated a by-product that was recognized by pharmacologist Herbert Keller as an analog of <a href="Glutethimide.htm" tppabs="https://ptable.com/wiki/compounds/A/Glutethimide" title="Glutethimide">glutethimide</a>, a sedative. The medicinal chemistry work turned to improving the lead compound into a suitable drug: the result was thalidomide.  The toxicity was examined in several animals, and the drug was introduced in 1956 as a sedative; it was never tested on pregnant women.<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>

<p>Researchers at Chemie Grünenthal found that thalidomide was a particularly effective antiemetic that had an inhibitory effect on morning sickness.<span class="mw-ref" id="cite_ref-pmid15172781_31-0"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> On October 1, 1957, the company launched thalidomide and began marketing it under the trade name Contergan.<span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-Bombay_33-0"><a href="#cite_note-Bombay-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> It was proclaimed a "wonder drug" for insomnia, coughs, colds and headaches.<span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p> 

<p>During this period, the use of medications during pregnancy was not strictly controlled, and drugs were not thoroughly tested for potential harm to the fetus.<span class="mw-ref" id="cite_ref-pmid15172781_31-1"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> Thousands of pregnant women took the drug to relieve their symptoms. At the time of the drug's development, scientists did not believe any drug taken by a pregnant woman could pass across the placental barrier and harm the developing fetus,<span class="mw-ref" id="cite_ref-Chem1994_35-0"><a href="#cite_note-Chem1994-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> even though the effect of alcohol on fetal development had been documented by case studies on alcoholic mothers since at least 1957.<span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span> There soon appeared reports of abnormalities in children being born to mothers using thalidomide. In late 1959, it was noticed that peripheral neuritis developed in patients who took the drug over a period of time, and it was only after this point that thalidomide ceased to be provided over the counter.<span class="mw-ref" id="cite_ref-37"><a href="#cite_note-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>

<p>While initially considered safe, the drug was responsible for teratogenic deformities in children born after their mothers used it during pregnancies, prior to the third trimester. In November 1961, thalidomide was taken off the market due to massive pressure from the press and public.<span class="mw-ref" id="cite_ref-50year_38-0"><a href="#cite_note-50year-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Experts estimate that the drug thalidomide led to the death of approximately 2,000 children and serious birth defects in more than 10,000 children, about 5,000 of them in West Germany. The regulatory authorities in East Germany did not approve thalidomide.<span class="mw-ref" id="cite_ref-oncozine.com_39-0"><a href="#cite_note-oncozine.com-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> One reason for the initially unobserved side effects of the drug and the subsequent approval in West Germany was that at that time drugs did not have to be tested for teratogenic effects. They had been tested on rodents only, as was usual at the time.<span class="mw-ref" id="cite_ref-VFA_40-0"><a href="#cite_note-VFA-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span></p>

<p>In the UK, the British pharmaceutical company The Distillers Company (Biochemicals) Ltd, a subsidiary of Distillers Co. Ltd (now part of Diageo plc), marketed thalidomide under the brand name Distaval as a remedy for morning sickness throughout the UK, Australia and New Zealand. Their advertisement claimed that "Distaval can be given with complete safety to pregnant women and nursing mothers without adverse effect on mother or child...Outstandingly safe Distaval has been prescribed for nearly three years in this country."<span class="mw-ref" id="cite_ref-oncozine.com_39-1"><a href="#cite_note-oncozine.com-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> Globally, more pharmaceutical companies started to produce and market the drug under license from Chemie Grünenthal. By the mid-1950s, 14 pharmaceutical companies were marketing thalidomide in 46 countries under at least 37 different trade names.</p>

<p>In the US, representatives from Chemie Grünenthal approached Smith, Kline &amp; French (SKF), now GlaxoSmithKline (GSK), with a request to market and distribute the drug in North America. A memorandum rediscovered in 2010 in the archives of the FDA shows that, as part of its in-licensing approach, Smith, Kline and French conducted animal tests and ran a clinical trial of the drug in the US involving 875 people, including pregnant women, in 1956–57. In 1956, researchers at SKF involved in clinical trials noted that even when used in very high doses, thalidomide could not induce sleep in mice. And when administered at doses 50 to 650 times larger than that claimed by Chemie Grünenthal to be "sleep inducing", the researchers could still not achieve the hypnotic effect in animals that it had on humans. After completion of the trial, and based on reasons kept hidden for decades, SKF declined to commercialize the drug. Later, Chemie Grünenthal, in 1958, reached an agreement with William S Merrell Company in Cincinnati, Ohio, (later Richardson-Merrell, now part of Sanofi), to market and distribute thalidomide throughout the US<span class="mw-ref" id="cite_ref-oncozine.com_39-2"><a href="#cite_note-oncozine.com-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>

<p>The US FDA refused to approve thalidomide for marketing and distribution. However, the drug was distributed in large quantities for testing purposes, after the American distributor and manufacturer Richardson-Merrell had applied for its approval in September 1960. The official in charge of the FDA review, Frances Oldham Kelsey, did not rely on information from the company, which did not include any test results. Richardson-Merrell was called on to perform tests and report the results. The company demanded approval six times, and was refused each time. Nevertheless, a total of 17 children with thalidomide-induced malformations were born in the US. Oldham Kelsey was given a Presidential award for distinguished service from the federal government for not allowing thalidomide to be approved for sale in the US.<span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span></p>

<p>In Canada, the history of the drug thalidomide dates back to April 1, 1961. There were many different forms sold, with the most common variant being Talimol.<span class="mw-ref" id="cite_ref-pmid14076167_42-0"><a href="#cite_note-pmid14076167-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> Two months after Talimol went on sale, pharmaceutical companies sent physicians letters warning about the risk of birth defects.<span class="mw-ref" id="cite_ref-pmid14076167_42-1"><a href="#cite_note-pmid14076167-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span> It was not until March 2, 1962, that both drugs were banned from the Canadian market by the FDD, and soon afterward physicians were warned to destroy their supplies.<span class="mw-ref" id="cite_ref-pmid14076167_42-2"><a href="#cite_note-pmid14076167-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Leprosy_treatment">Leprosy treatment</h3></summary>
    
<p>In 1964, Israeli physician Jacob Sheskin administered thalidomide to a patient critically ill with leprosy. The patient exhibited erythema nodosum leprosum (ENL), a painful skin condition, one of the complications of leprosy. This was attempted despite the ban on thalidomide's use, but results were favourable: the patient slept for hours and was able to get out of bed without aid upon awakening. A clinical trial studying the use of thalidomide in leprosy soon followed.<span class="mw-ref" id="cite_ref-Silverman_43-0"><a href="#cite_note-Silverman-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></p>

<p>Thalidomide has been used by Brazilian physicians as the drug of choice for the treatment of severe ENL since 1965, and by 1996, at least 33 cases of thalidomide embryopathy were recorded in people born in Brazil after 1965.<span class="mw-ref" id="cite_ref-44"><a href="#cite_note-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span> Since 1994, the production, dispensing, and prescription of thalidomide have been strictly controlled, requiring women to use two forms of birth control and submit to regular pregnancy tests. Despite this, cases of thalidomide embryopathy continue,<span class="mw-ref" id="cite_ref-45"><a href="#cite_note-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span><span class="mw-ref" id="cite_ref-46"><a href="#cite_note-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span> with at least 100 cases identified in Brazil between 2005 and 2010.<span class="mw-ref" id="cite_ref-47"><a href="#cite_note-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> 5.8 million thalidomide pills were distributed throughout Brazil in this time period, largely to poor Brazilians in areas with poor access to healthcare, and these cases have occurred despite the controls.</p>

<p>In 1998, the FDA approved the drug's use in the treatment of ENL.<span class="mw-ref" id="cite_ref-nyt-fda_48-0"><a href="#cite_note-nyt-fda-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> Because of thalidomide's potential for causing birth defects, the drug may be distributed only under tightly controlled conditions. The FDA required that Celgene Corporation, which planned to market thalidomide under the brand name <i>Thalomid</i>, establish a system for thalidomide education and prescribing safety (STEPS) oversight program. The conditions required under the program include limiting prescription and dispensing rights to authorized prescribers and pharmacies only, keeping a registry of all patients prescribed thalidomide, providing extensive patient education about the risks associated with the drug, and providing periodic pregnancy tests for women who take the drug.<span class="mw-ref" id="cite_ref-nyt-fda_48-1"><a href="#cite_note-nyt-fda-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span></p>

<p>In 2010, the World Health Organization (WHO) stated that it did not recommend thalidomide for leprosy due to the difficulty of adequately controlling its use, and due to the availability of <a href="Clofazimine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clofazimine" title="Clofazimine">clofazimine</a>.<span class="mw-ref" id="cite_ref-49"><a href="#cite_note-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cancer_treatment">Cancer treatment</h3></summary>
    
<p>Shortly after the teratogenic properties of thalidomide were recognized in the mid-1960s, its anti-cancer potential was explored and two clinical trials were conducted in people with advanced cancer, including some people with multiple myeloma; the trials were inconclusive.<span class="mw-ref" id="cite_ref-Kyle_50-0"><a href="#cite_note-Kyle-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></p>

<p>Little further work was done with thalidomide in cancer until the 1990s.<span class="mw-ref" id="cite_ref-Kyle_50-1"><a href="#cite_note-Kyle-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span></p>

<p>Judah Folkman pioneered studies into the role of angiogenesis (the proliferation and growth of blood vessels) in the development of cancer, and in the early 1970s had shown that solid tumors could not expand without it.<span class="mw-ref" id="cite_ref-NASbio_51-0"><a href="#cite_note-NASbio-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span><span class="mw-ref" id="cite_ref-Beilenberg_52-0"><a href="#cite_note-Beilenberg-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> In 1993 he surprised the scientific world by hypothesizing the same was true of blood cancers,<span class="mw-ref" id="cite_ref-Folkman_53-0"><a href="#cite_note-Folkman-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span> and the next year he published work showing that a biomarker of angiogenesis was higher in all people with cancer, but especially high in people with blood cancers, and other evidence emerged as well.<span class="mw-ref" id="cite_ref-54"><a href="#cite_note-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span>  Meanwhile, a member of his lab, Robert D'Amato, who was looking for angiogenesis inhibitors, discovered in 1994 that thalidomide inhibited angiogenesis<span class="mw-ref" id="cite_ref-55"><a href="#cite_note-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> and was effective in suppressing tumor growth in rabbits.<span class="mw-ref" id="cite_ref-56"><a href="#cite_note-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> Around that time, the wife of a man who was dying of multiple myeloma and whom standard treatments had failed, called Folkman asking him about his anti-angiogenesis ideas.<span class="mw-ref" id="cite_ref-Beilenberg_52-1"><a href="#cite_note-Beilenberg-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span>  Folkman persuaded the patient's doctor to try thalidomide, and that doctor conducted a clinical trial of thalidomide for people with multiple myeloma in which about a third of the subjects responded to the treatment.<span class="mw-ref" id="cite_ref-Beilenberg_52-2"><a href="#cite_note-Beilenberg-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span>  The results of that trial were published in the New England Journal of Medicine in 1999.<span class="mw-ref" id="cite_ref-Beilenberg_52-3"><a href="#cite_note-Beilenberg-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-nejm-myeloma_57-0"><a href="#cite_note-nejm-myeloma-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span></p>

<p>After further work was done by Celgene and others, in 2006 the U.S.<span>&nbsp;</span>Food and Drug Administration granted accelerated approval for thalidomide in combination with dexamethasone for the treatment of newly diagnosed multiple myeloma patients.<span class="mw-ref" id="cite_ref-Beilenberg_52-4"><a href="#cite_note-Beilenberg-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-58"><a href="#cite_note-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Birth_defect_crisis">Birth defect crisis</h3></summary>
    

<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/NCP14053.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/NCP14053.jpg" data-file-width="2840" data-file-height="1838" data-file-type="bitmap" height="142" width="220"><div class="thumbcaption" style="text-align: left">Baby born to a mother who had taken thalidomide while pregnant</div></div></div>
<p>In the late 1950s and early 1960s, more than 10,000 children in 46 countries were born with deformities, such as phocomelia, as a consequence of thalidomide use.<span class="mw-ref" id="cite_ref-Bren_59-0"><a href="#cite_note-Bren-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> The severity and location of the deformities depended on how many days into the pregnancy the mother was before beginning treatment; thalidomide taken on the 20th day of pregnancy caused central brain damage, day 21 would damage the eyes, day 22 the ears and face, day 24 the arms, and leg damage would occur if taken up to day 28. Thalidomide did not damage the fetus if taken after 42 days gestation.<span class="mw-ref" id="cite_ref-50year_38-1"><a href="#cite_note-50year-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>

<p>It is not known exactly how many worldwide victims of the drug there have been, although estimates range from 10,000 to 20,000.<span class="mw-ref" id="cite_ref-nyt-answers_60-0"><a href="#cite_note-nyt-answers-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span> Despite the side effects, thalidomide was sold in pharmacies in Canada until 1962.<span class="mw-ref" id="cite_ref-pmid14076167_42-3"><a href="#cite_note-pmid14076167-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span><span class="mw-ref" id="cite_ref-61"><a href="#cite_note-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Notable_cases">Notable cases</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Niko_von_Glasow.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Niko_von_Glasow.jpg" data-file-width="480" data-file-height="640" data-file-type="bitmap" height="293" width="220"><div class="thumbcaption" style="text-align: left">Niko von Glasow, German filmmaker</div></div></div>
<ul><li>Lorraine Mercer  MBE  of the United Kingdom, born with phocomelia of both arms and legs, is the only thalidomide survivor to carry the Olympic Torch.<span class="mw-ref" id="cite_ref-Tamplin_62-0"><a href="#cite_note-Tamplin-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span></li>
<li>Thomas Quasthoff, an internationally acclaimed bass-baritone, who describes himself: "1.34 meters tall, short arms, seven fingers<span>&nbsp;</span>— four right, three left<span>&nbsp;</span>— large, relatively well-formed head, brown eyes, distinctive lips; profession: singer".<span class="mw-ref" id="cite_ref-63"><a href="#cite_note-63" style="counter-reset: mw-Ref 63;"><span class="mw-reflink-text">[63]</span></a></span></li>
<li>Niko von Glasow produced a documentary called <i>NoBody's Perfect</i>, based on the lives of 12 people affected by the drug, which was released in 2008.<span class="mw-ref" id="cite_ref-64"><a href="#cite_note-64" style="counter-reset: mw-Ref 64;"><span class="mw-reflink-text">[64]</span></a></span><span class="mw-ref" id="cite_ref-65"><a href="#cite_note-65" style="counter-reset: mw-Ref 65;"><span class="mw-reflink-text">[65]</span></a></span></li>
<li>Mercédes Benegbi, born with phocomelia of both arms, drove the successful campaign for compensation from her government for Canadians who were affected by thalidomide.<span class="mw-ref" id="cite_ref-66"><a href="#cite_note-66" style="counter-reset: mw-Ref 66;"><span class="mw-reflink-text">[66]</span></a></span></li>
<li>Mat Fraser, born with phocomelia of both arms, is an English rock musician, actor, writer and performance artist. He produced a 2002 television documentary "Born Freak", which looked at this historical tradition and its relevance to modern disabled performers. This work has become the subject of academic analysis in the field of disability studies.<span class="mw-ref" id="cite_ref-67"><a href="#cite_note-67" style="counter-reset: mw-Ref 67;"><span class="mw-reflink-text">[67]</span></a></span></li></ul>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Change_in_drug_regulations">Change in drug regulations</h3></summary>
    
<p>The disaster prompted many countries to introduce tougher rules for the testing and licensing of drugs, such as the Kefauver Harris Amendment<span class="mw-ref" id="cite_ref-68"><a href="#cite_note-68" style="counter-reset: mw-Ref 68;"><span class="mw-reflink-text">[68]</span></a></span>  (U.S.), Directive 65/65/EEC1 (E.U.),<span class="mw-ref" id="cite_ref-69"><a href="#cite_note-69" style="counter-reset: mw-Ref 69;"><span class="mw-reflink-text">[69]</span></a></span> and the Medicines Act 1968 (UK).<span class="mw-ref" id="cite_ref-70"><a href="#cite_note-70" style="counter-reset: mw-Ref 70;"><span class="mw-reflink-text">[70]</span></a></span><span class="mw-ref" id="cite_ref-71"><a href="#cite_note-71" style="counter-reset: mw-Ref 71;"><span class="mw-reflink-text">[71]</span></a></span> In the United States, the new regulations strengthened the FDA, among other ways, by requiring applicants to prove efficacy and to disclose all side effects encountered in testing.<span class="mw-ref" id="cite_ref-Bren_59-1"><a href="#cite_note-Bren-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span> The FDA subsequently initiated the Drug Efficacy Study Implementation to reclassify drugs already on the market.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Quality_of_life">Quality of life</h3></summary>
    
<p>In the 1960s, thalidomide was successfully marketed as a safer alternative to <a href="Barbiturate.htm" tppabs="https://ptable.com/wiki/compounds/A/Barbiturate" title="Barbiturate">barbiturates</a>. Due to a successful marketing campaign, thalidomide was widely used by pregnant women during the first trimester of pregnancy. However, thalidomide is a teratogenic substance, and a proportion of children born during the 1960s were afflicted with a syndrome known as thalidomide embryopathy (TE).<span class="mw-ref" id="cite_ref-Wadman_e0210222_72-0"><a href="#cite_note-Wadman_e0210222-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span> Of these babies born with TE, "about 40% of them died before their first birthday".<span class="mw-ref" id="cite_ref-40_years_later:_the_health_related_73-0"><a href="#cite_note-40_years_later:_the_health_related-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span> The surviving individuals are now middle-aged and they report experiencing challenges (physical, psychological, and socioeconomic) related to TE.</p>

<p>Individuals born with TE frequently experience a wide variety of health problems secondary to their TE. These health conditions include both physical and psychological conditions. When compared to individuals of similar demographic profiles, those born with TE report less satisfaction with their quality of life and their overall health.<span class="mw-ref" id="cite_ref-Wadman_e0210222_72-1"><a href="#cite_note-Wadman_e0210222-72" style="counter-reset: mw-Ref 72;"><span class="mw-reflink-text">[72]</span></a></span> Access to health care services can also be a challenge for these people, and women in particular have experienced difficulty in locating healthcare professionals who can understand and embrace their needs.<span class="mw-ref" id="cite_ref-40_years_later:_the_health_related_73-1"><a href="#cite_note-40_years_later:_the_health_related-73" style="counter-reset: mw-Ref 73;"><span class="mw-reflink-text">[73]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>Brand names include Contergan, Thalomid, Talidex, Talizer, Neurosedyn, Distaval and many others.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cost">Cost</h3></summary>
    
<p>In the United Kingdom, it costs the NHS about £1,194 per month as of 2018.<span class="mw-ref" id="cite_ref-BNF76_4-4"><a href="#cite_note-BNF76-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> This amount in the United States costs about US$9,236 as of 2019.<span class="mw-ref" id="cite_ref-Price2019_9-1"><a href="#cite_note-Price2019-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Research efforts have been focused on determining how thalidomide causes birth defects and its other activities in the human body, efforts to develop safer analogs, and efforts to find further uses for thalidomide.</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Thalidomide_analogs">Thalidomide analogs</h3></summary>
    

<p>The exploration of the antiangiogenic and immunomodulatory activities of thalidomide has led to the study and creation of thalidomide analogs.<span class="mw-ref" id="cite_ref-pmid10447943_74-0"><a href="#cite_note-pmid10447943-74" style="counter-reset: mw-Ref 74;"><span class="mw-reflink-text">[74]</span></a></span><span class="mw-ref" id="cite_ref-pmid11740816_75-0"><a href="#cite_note-pmid11740816-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span> Celgene has sponsored numerous clinical trials with analogues to thalidomide, such as <a href="Lenalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lenalidomide" title="Lenalidomide">lenalidomide</a>, that are substantially more powerful and have fewer side effects<span>&nbsp;</span>— except for greater myelosuppression.<span class="mw-ref" id="cite_ref-76"><a href="#cite_note-76" style="counter-reset: mw-Ref 76;"><span class="mw-reflink-text">[76]</span></a></span> In 2005, Celgene received FDA approval for <a href="Lenalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lenalidomide" title="Lenalidomide">lenalidomide</a> (Revlimid) as the first commercially useful derivative. Revlimid is available only in a restricted distribution setting to avoid its use during pregnancy. Further studies are being conducted to find safer compounds with useful qualities. Another more potent analog, pomalidomide, is now FDA approved.<span class="mw-ref" id="cite_ref-77"><a href="#cite_note-77" style="counter-reset: mw-Ref 77;"><span class="mw-reflink-text">[77]</span></a></span> Additionally, apremilast was approved by the FDA in March 2014. These thalidomide analogs can be used to treat different diseases, or used in a regimen to fight two conditions.<span class="mw-ref" id="cite_ref-78"><a href="#cite_note-78" style="counter-reset: mw-Ref 78;"><span class="mw-reflink-text">[78]</span></a></span></p>

<p>Interest turned to pomalidomide, a derivative of thalidomide marketed by Celgene. It is a very active anti-angiogenic agent <span class="mw-ref" id="cite_ref-pmid11740816_75-1"><a href="#cite_note-pmid11740816-75" style="counter-reset: mw-Ref 75;"><span class="mw-reflink-text">[75]</span></a></span>  and also acts as an immunomodulator. Pomalidomide was approved in February 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.<span class="mw-ref" id="cite_ref-P1_79-0"><a href="#cite_note-P1-79" style="counter-reset: mw-Ref 79;"><span class="mw-reflink-text">[79]</span></a></span> It received a similar approval from the European Commission in August 2013, and is expected to be marketed in Europe under the brand name <b>Imnovid</b>.<span class="mw-ref" id="cite_ref-P2_80-0"><a href="#cite_note-P2-80" style="counter-reset: mw-Ref 80;"><span class="mw-reflink-text">[80]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Clinical_research">Clinical research</h3></summary>
    
<p>There is no conclusive evidence that thalidomide or <a href="Lenalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lenalidomide" title="Lenalidomide">lenalidomide</a> is useful to bring about or maintain remission in Crohn's disease.<span class="mw-ref" id="cite_ref-81"><a href="#cite_note-81" style="counter-reset: mw-Ref 81;"><span class="mw-reflink-text">[81]</span></a></span><span class="mw-ref" id="cite_ref-82"><a href="#cite_note-82" style="counter-reset: mw-Ref 82;"><span class="mw-reflink-text">[82]</span></a></span></p>

<p>Thalidomide was studied in a Phase II trial for Kaposi's sarcoma, a rare soft-tissue cancer most commonly seen in the immunocompromised, that is caused by the Kaposi's sarcoma-associated herpesvirus (KSHV).<span class="mw-ref" id="cite_ref-83"><a href="#cite_note-83" style="counter-reset: mw-Ref 83;"><span class="mw-reflink-text">[83]</span></a></span><span class="mw-ref" id="cite_ref-pmid15172781_31-2"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>

<div class="div-col columns column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em;   ">
<ul><li>AIDS wasting syndrome,<span class="mw-ref" id="cite_ref-84"><a href="#cite_note-84" style="counter-reset: mw-Ref 84;"><span class="mw-reflink-text">[84]</span></a></span> associated diarrhoea<span class="mw-ref" id="cite_ref-85"><a href="#cite_note-85" style="counter-reset: mw-Ref 85;"><span class="mw-reflink-text">[85]</span></a></span></li>
<li>Renal cell carcinoma (RCC)<span class="mw-ref" id="cite_ref-pmid15172781_31-3"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-86"><a href="#cite_note-86" style="counter-reset: mw-Ref 86;"><span class="mw-reflink-text">[86]</span></a></span></li>
<li>Glioblastoma multiforme<span class="mw-ref" id="cite_ref-pmid15172781_31-4"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Prostate cancer<span class="mw-ref" id="cite_ref-pmid15172781_31-5"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Melanoma<span class="mw-ref" id="cite_ref-pmid15172781_31-6"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Colorectal cancer<span class="mw-ref" id="cite_ref-pmid15172781_31-7"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Crohn's disease<span class="mw-ref" id="cite_ref-pmid15172781_31-8"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Rheumatoid arthritis<span class="mw-ref" id="cite_ref-pmid15172781_31-9"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Behcet's syndrome<span class="mw-ref" id="cite_ref-87"><a href="#cite_note-87" style="counter-reset: mw-Ref 87;"><span class="mw-reflink-text">[87]</span></a></span></li>
<li>Breast cancer<span class="mw-ref" id="cite_ref-pmid15172781_31-10"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Head and neck cancer<span class="mw-ref" id="cite_ref-pmid15172781_31-11"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Ovarian cancer<span class="mw-ref" id="cite_ref-pmid15172781_31-12"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Chronic heart failure<span class="mw-ref" id="cite_ref-pmid15172781_31-13"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Graft-versus-host disease<span class="mw-ref" id="cite_ref-pmid15172781_31-14"><a href="#cite_note-pmid15172781-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></li>
<li>Tuberculous meningitis<span class="mw-ref" id="cite_ref-88"><a href="#cite_note-88" style="counter-reset: mw-Ref 88;"><span class="mw-reflink-text">[88]</span></a></span></li></ul>
</div>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<div class="div-col columns column-width" style="-moz-column-width: 22em; -webkit-column-width: 22em; column-width: 22em;   ">
<ul><li>Pharmacovigilance</li>
<li>Immunomodulatory drug</li>
<li>Discovery and development of thalidomide and its analogs</li>
<li>Drug of last resort</li>
<li>Health crisis</li>
<li>Holt-Oram syndrome</li>
<li>Category:People with phocomelia</li>
<li><a href="Diethylstilbestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethylstilbestrol" title="Diethylstilbestrol">Diethylstilbestrol</a></li></ul>
</div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite id="CITEREFReference-OED-Thalidomide" class="citation cs1"><a href="javascript:if(confirm('http://oed.com/search?searchType=dictionary&q=Thalidomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://oed.com/search?searchType=dictionary&q=Thalidomide'" tppabs="http://oed.com/search?searchType=dictionary&q=Thalidomide" class="external text external">"Thalidomide"</a>. <i>Oxford English Dictionary</i> (3rd ed.). Oxford University Press. September 2005.</cite><span>&nbsp;</span><span style="font-size:0.95em; font-size:90%; color:#555">(Subscription or <a href="javascript:if(confirm('https://www.oed.com/public/login/loggingin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.oed.com/public/login/loggingin#withyourlibrary'" tppabs="https://www.oed.com/public/login/loggingin#withyourlibrary" class="external text external">UK public library membership</a> required.)</span></span></li><li id="cite_note-clinp-2"> <span id="mw-reference-text-cite_note-clinp-2" class="mw-reference-text"><cite id="CITEREFTeoColburnTracewellKook2004" class="citation journal cs1">Teo SK, Colburn WA, Tracewell WG, Kook KA, Stirling DI, Jaworsky MS, Scheffler MA, Thomas SD, Laskin OL (2004). "Clinical pharmacokinetics of thalidomide". <i>Clinical Pharmacokinetics</i>. <b>43</b> (5): 311–27. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-200443050-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-200443050-00004'" tppabs="https://doi.org/10.2165%2F00003088-200443050-00004" class="external text external">10.2165/00003088-200443050-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15080764  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15080764'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15080764" class="external text external">15080764</a>.</cite></span></li><li id="cite_note-AHFS2019-3"> <span id="mw-reference-text-cite_note-AHFS2019-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/thalidomide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/thalidomide.html'" tppabs="https://www.drugs.com/monograph/thalidomide.html" class="external text external">"Thalidomide Monograph for Professionals"</a>. <i>Drugs.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">14 November</span> 2019</span>.</cite></span></li><li id="cite_note-BNF76-4"> <span id="mw-reference-text-cite_note-BNF76-4" class="mw-reference-text"><cite class="citation book cs1"><i>British national formulary<span>&nbsp;</span>: BNF 76</i> (76 ed.). Pharmaceutical Press. 2018. p.<span>&nbsp;</span>936. ISBN<span>&nbsp;</span><bdi>9780857113382</bdi>.</cite></span></li><li id="cite_note-OUP2003-5"> <span id="mw-reference-text-cite_note-OUP2003-5" class="mw-reference-text"><cite id="CITEREFCuthbert2003" class="citation book cs1">Cuthbert A (2003). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/oxfordcompaniont0000unse_z0k4/page/682  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/oxfordcompaniont0000unse_z0k4/page/682'" tppabs="https://archive.org/details/oxfordcompaniont0000unse_z0k4/page/682" class="external text external"><i>The Oxford Companion to the Body</i></a></span>. Oxford University Press. p.<span>&nbsp;</span><a href="javascript:if(confirm('https://archive.org/details/oxfordcompaniont0000unse_z0k4/page/682  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/oxfordcompaniont0000unse_z0k4/page/682'" tppabs="https://archive.org/details/oxfordcompaniont0000unse_z0k4/page/682" class="external text external">682</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Facref%2F9780198524038.001.0001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Facref%2F9780198524038.001.0001'" tppabs="https://doi.org/10.1093%2Facref%2F9780198524038.001.0001" class="external text external">10.1093/acref/9780198524038.001.0001</a>. ISBN<span>&nbsp;</span><bdi>9780198524038</bdi>.</cite></span></li><li id="cite_note-Mill1991-6"> <span id="mw-reference-text-cite_note-Mill1991-6" class="mw-reference-text"><cite id="CITEREFMiller1991" class="citation journal cs1">Miller MT (1991). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298636'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298636" class="external text external">"Thalidomide Embryopathy: A Model for the Study of Congenital Incomitant Horizontal Strabismus"</a>. <i>Transactions of the American Ophthalmological Society</i>. <b>81</b>: 623–674. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298636  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298636'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1298636" class="external text external">1298636</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1808819  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1808819'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1808819" class="external text external">1808819</a>.</cite></span></li><li id="cite_note-Lou2004-7"> <span id="mw-reference-text-cite_note-Lou2004-7" class="mw-reference-text"><cite id="CITEREFLoueSajatovic2004" class="citation book cs1">Loue S, Sajatovic M (2004). <a href="javascript:if(confirm('https://books.google.ca/books?id=LbHWgd-mDbsC&pg=PA644  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.ca/books?id=LbHWgd-mDbsC&pg=PA644'" tppabs="https://books.google.ca/books?id=LbHWgd-mDbsC&pg=PA644" class="external text external"><i>Encyclopedia of Women's Health</i></a>. Springer Science &amp; Business Media. p.<span>&nbsp;</span>644. ISBN<span>&nbsp;</span><bdi>9780306480737</bdi>.</cite></span></li><li id="cite_note-WHO21st-8"> <span id="mw-reference-text-cite_note-WHO21st-8" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation journal cs1">World Health Organization (2019). "World Health Organization model list of essential medicines: 21st list 2019". hdl:<a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a>.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-Price2019-9"> <span id="mw-reference-text-cite_note-Price2019-9" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/price-guide/thalomid  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/price-guide/thalomid'" tppabs="https://www.drugs.com/price-guide/thalomid" class="external text external">"Thalomid Prices, Coupons &amp; Patient Assistance Programs"</a>. <i>Drugs.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">15 November</span> 2019</span>.</cite></span></li><li id="cite_note-UKlabel2017-10"> <span id="mw-reference-text-cite_note-UKlabel2017-10" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.medicines.org.uk/emc/medicine/21005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicines.org.uk/emc/medicine/21005'" tppabs="https://www.medicines.org.uk/emc/medicine/21005" class="external text external">"Thalidomide Celgene 50 mg Hard Capsules - Summary of Product Characteristics"</a>. UK Electronic Medicines Compendium. January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">26 June</span> 2017</span>.</cite></span></li><li id="cite_note-USlabel2017-11"> <span id="mw-reference-text-cite_note-USlabel2017-11" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020785s061lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020785s061lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020785s061lbl.pdf" class="external text external">"US Thalomid label"</a> <span class="cs1-format">(PDF)</span>. FDA. January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">26 June</span> 2017</span>.</cite> For label updates see <a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020785  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020785'" tppabs="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020785" class="external text external">FDA index page for NDA 020785</a></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFBuonsensoSerrantiValentini2010" class="citation journal cs1">Buonsenso D, Serranti D, Valentini P (October 2010). <a href="javascript:if(confirm('https://web.archive.org/web/20160818223324/http://www.europeanreview.org/wp/wp-content/uploads/827.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160818223324/http://www.europeanreview.org/wp/wp-content/uploads/827.pdf'" tppabs="https://web.archive.org/web/20160818223324/http://www.europeanreview.org/wp/wp-content/uploads/827.pdf" class="external text external">"Management of central nervous system tuberculosis in children: light and shade"</a> <span class="cs1-format">(PDF)</span>. <i>European Review for Medical and Pharmacological Sciences</i>. <b>14</b> (10): 845–53. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21222370  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21222370'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21222370" class="external text external">21222370</a>. Archived from <a href="javascript:if(confirm('http://www.europeanreview.org/wp/wp-content/uploads/827.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.europeanreview.org/wp/wp-content/uploads/827.pdf'" tppabs="http://www.europeanreview.org/wp/wp-content/uploads/827.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2016-08-18.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFvan_ToornSolomons2014" class="citation journal cs1">van Toorn R, Solomons R (March 2014). "Update on the diagnosis and management of tuberculous meningitis in children". <i>Seminars in Pediatric Neurology</i>. <b>21</b> (1): 12–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.spen.2014.01.006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.spen.2014.01.006'" tppabs="https://doi.org/10.1016%2Fj.spen.2014.01.006" class="external text external">10.1016/j.spen.2014.01.006</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24655399  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24655399'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24655399" class="external text external">24655399</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite id="CITEREFYangKimAntaya2015" class="citation journal cs1">Yang CS, Kim C, Antaya RJ (April 2015). "Review of thalidomide use in the pediatric population". <i>Journal of the American Academy of Dermatology</i>. <b>72</b> (4): 703–11. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jaad.2015.01.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jaad.2015.01.002'" tppabs="https://doi.org/10.1016%2Fj.jaad.2015.01.002" class="external text external">10.1016/j.jaad.2015.01.002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25617013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25617013'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25617013" class="external text external">25617013</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFWolffGerbitzAyukKiani2010" class="citation journal cs1">Wolff D, Gerbitz A, Ayuk F, Kiani A, Hildebrandt GC, Vogelsang GB, Elad S, Lawitschka A, Socie G, Pavletic SZ, Holler E, Greinix H (December 2010). <a href="javascript:if(confirm('http://www.bbmt.org/article/S1083-8791(10)00275-2/fulltext  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.bbmt.org/article/S1083-8791(10)00275-2/fulltext'" tppabs="http://www.bbmt.org/article/S1083-8791(10)00275-2/fulltext" class="external text external">"Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD"</a>. <i>Biology of Blood and Marrow Transplantation</i>. <b>16</b> (12): 1611–28. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.bbmt.2010.06.015  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.bbmt.2010.06.015'" tppabs="https://doi.org/10.1016%2Fj.bbmt.2010.06.015" class="external text external">10.1016/j.bbmt.2010.06.015</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20601036  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20601036'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20601036" class="external text external">20601036</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFWolffSchleuningvon_HarsdorfBacher2011" class="citation journal cs1">Wolff D, Schleuning M, von Harsdorf S, Bacher U, Gerbitz A, Stadler M, Ayuk F, Kiani A, Schwerdtfeger R, Vogelsang GB, Kobbe G, Gramatzki M, Lawitschka A, Mohty M, Pavletic SZ, Greinix H, Holler E (January 2011). <a href="javascript:if(confirm('http://www.bbmt.org/article/S1083-8791(10)00223-5/fulltext  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.bbmt.org/article/S1083-8791(10)00223-5/fulltext'" tppabs="http://www.bbmt.org/article/S1083-8791(10)00223-5/fulltext" class="external text external">"Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease"</a>. <i>Biology of Blood and Marrow Transplantation</i>. <b>17</b> (1): 1–17. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.bbmt.2010.05.011  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.bbmt.2010.05.011'" tppabs="https://doi.org/10.1016%2Fj.bbmt.2010.05.011" class="external text external">10.1016/j.bbmt.2010.05.011</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20685255  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20685255'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20685255" class="external text external">20685255</a>.</cite></span></li><li id="cite_note-toxmech2009-17"> <span id="mw-reference-text-cite_note-toxmech2009-17" class="mw-reference-text"><cite id="CITEREFSmith2009" class="citation journal cs1">Smith SW (July 2009). <a href="javascript:if(confirm('https://doi.org/10.1093/toxsci/kfp097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/toxsci/kfp097'" tppabs="https://doi.org/10.1093/toxsci/kfp097" class="external text external">"Chiral toxicology: it's the same thing...only different"</a>. <i>Toxicological Sciences</i>. <b>110</b> (1): 4–30. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Ftoxsci%2Fkfp097  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Ftoxsci%2Fkfp097'" tppabs="https://doi.org/10.1093%2Ftoxsci%2Fkfp097" class="external text external">10.1093/toxsci/kfp097</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19414517  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19414517'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19414517" class="external text external">19414517</a>.</cite></span></li><li id="cite_note-TGA-18"> <span id="mw-reference-text-cite_note-TGA-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-03581-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-03581-3'" tppabs="https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2010-PI-03581-3" class="external text external">"THALOMID® CAPSULES"</a> <span class="cs1-format">(PDF)</span>. <i>TGA eBusiness Services</i>. Celgene Pty Limited. 21 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">17 January</span> 2014</span>.</cite></span></li><li id="cite_note-Stephens2000-19"> <span id="mw-reference-text-cite_note-Stephens2000-19" class="mw-reference-text"><cite id="CITEREFStephensBundeFillmore2000" class="citation journal cs1">Stephens TD, Bunde CJ, Fillmore BJ (June 2000). "Mechanism of action in thalidomide teratogenesis". <i>Biochemical Pharmacology</i>. <b>59</b> (12): 1489–99. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0006-2952%2899%2900388-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0006-2952%2899%2900388-3'" tppabs="https://doi.org/10.1016%2FS0006-2952%2899%2900388-3" class="external text external">10.1016/S0006-2952(99)00388-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10799645  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10799645'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10799645" class="external text external">10799645</a>.</cite></span></li><li id="cite_note-Vargesson2015-20"> <span id="mw-reference-text-cite_note-Vargesson2015-20" class="mw-reference-text"><cite id="CITEREFVargesson2015" class="citation journal cs1">Vargesson N (June 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737249  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737249'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737249" class="external text external">"Thalidomide-induced teratogenesis: history and mechanisms"</a>. <i>Birth Defects Research. Part C, Embryo Today</i>. <b>105</b> (2): 140–56. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fbdrc.21096  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fbdrc.21096'" tppabs="https://doi.org/10.1002%2Fbdrc.21096" class="external text external">10.1002/bdrc.21096</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737249  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737249'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737249" class="external text external">4737249</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/26043938  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/26043938'" tppabs="https://pubmed.ncbi.nlm.nih.gov/26043938" class="external text external">26043938</a>.</cite></span></li><li id="cite_note-Kim2011-21"> <span id="mw-reference-text-cite_note-Kim2011-21" class="mw-reference-text"><cite id="CITEREFKimScialli2011" class="citation journal cs1">Kim JH, Scialli AR (July 2011). <a href="javascript:if(confirm('https://doi.org/10.1093/toxsci/kfr088  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/toxsci/kfr088'" tppabs="https://doi.org/10.1093/toxsci/kfr088" class="external text external">"Thalidomide: the tragedy of birth defects and the effective treatment of disease"</a>. <i>Toxicological Sciences</i>. <b>122</b> (1): 1–6. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Ftoxsci%2Fkfr088  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Ftoxsci%2Fkfr088'" tppabs="https://doi.org/10.1093%2Ftoxsci%2Fkfr088" class="external text external">10.1093/toxsci/kfr088</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21507989  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21507989'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21507989" class="external text external">21507989</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFDonovanAnNowakYuan2018" class="citation journal cs1">Donovan KA, An J, Nowak RP, Yuan JC, Fink EC, Berry BC, Ebert BL, Fischer ES (1 August 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156078  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156078'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156078" class="external text external">"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray Syndrome"</a>. <i>eLife</i>. <b>7</b>. doi:<a href="javascript:if(confirm('https://doi.org/10.7554%2FeLife.38430  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7554%2FeLife.38430'" tppabs="https://doi.org/10.7554%2FeLife.38430" class="external text external">10.7554/eLife.38430</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156078  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156078'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156078" class="external text external">6156078</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30067223  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30067223'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30067223" class="external text external">30067223</a>.</cite><span style="position:relative; top: -2px;"><figure-inline><img src="../I/m/Open_Access_logo_PLoS_transparent.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Open_Access_logo_PLoS_transparent.svg.png" data-file-width="640" data-file-height="1000" data-file-type="drawing" height="14" width="9"></figure-inline></span>Note: the manuscript has been accepted, but not yet fully published, only available in PDF form and not yet assigned to a volume/issue.</span></li><li id="cite_note-LiuSu2010-23"> <span id="mw-reference-text-cite_note-LiuSu2010-23" class="mw-reference-text"><cite id="CITEREFLiuSuGengLiu2010" class="citation journal cs1">Liu B, Su L, Geng J, Liu J, Zhao G (October 2010). "Developments in nonsteroidal antiandrogens targeting the androgen receptor". <i>ChemMedChem</i>. <b>5</b> (10): 1651–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fcmdc.201000259  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fcmdc.201000259'" tppabs="https://doi.org/10.1002%2Fcmdc.201000259" class="external text external">10.1002/cmdc.201000259</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20853390  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20853390'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20853390" class="external text external">20853390</a>.</cite></span></li><li id="cite_note-NuttallWarrier2015-24"> <span id="mw-reference-text-cite_note-NuttallWarrier2015-24" class="mw-reference-text"><cite id="CITEREFNuttallWarrierGannon2015" class="citation journal cs1">Nuttall FQ, Warrier RS, Gannon MC (May 2015). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412434  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412434'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412434" class="external text external">"Gynecomastia and drugs: a critical evaluation of the literature"</a>. <i>European Journal of Clinical Pharmacology</i>. <b>71</b> (5): 569–78. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00228-015-1835-x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00228-015-1835-x'" tppabs="https://doi.org/10.1007%2Fs00228-015-1835-x" class="external text external">10.1007/s00228-015-1835-x</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412434  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412434'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412434" class="external text external">4412434</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25827472  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25827472'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25827472" class="external text external">25827472</a>.</cite></span></li><li id="cite_note-stereospecific44-25"> <span id="mw-reference-text-cite_note-stereospecific44-25" class="mw-reference-text"><cite id="CITEREFErikssonBjörkmanRothFyge1995" class="citation journal cs1">Eriksson T, Björkman S, Roth B, Fyge A, Höglund P (1995). "Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide". <i>Chirality</i>. <b>7</b> (1): 44–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fchir.530070109  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fchir.530070109'" tppabs="https://doi.org/10.1002%2Fchir.530070109" class="external text external">10.1002/chir.530070109</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7702998  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7702998'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7702998" class="external text external">7702998</a>.</cite></span></li><li id="cite_note-pmid14505639-26"> <span id="mw-reference-text-cite_note-pmid14505639-26" class="mw-reference-text"><cite id="CITEREFManCorralStirlingMuller2003" class="citation journal cs1">Man HW, Corral LG, Stirling DI, Muller GW (October 2003). "Alpha-fluoro-substituted thalidomide analogues". <i>Bioorganic &amp; Medicinal Chemistry Letters</i>. <b>13</b> (20): 3415–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0960-894X%2803%2900778-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0960-894X%2803%2900778-9'" tppabs="https://doi.org/10.1016%2FS0960-894X%2803%2900778-9" class="external text external">10.1016/S0960-894X(03)00778-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14505639  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14505639'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14505639" class="external text external">14505639</a>.</cite></span></li><li id="cite_note-Bartlett2004-27"> <span id="mw-reference-text-cite_note-Bartlett2004-27" class="mw-reference-text"><cite id="CITEREFBartlettDredgeDalgleish2004" class="citation journal cs1">Bartlett JB, Dredge K, Dalgleish AG (April 2004). "The evolution of thalidomide and its IMiD derivatives as anticancer agents". <i>Nature Reviews. Cancer</i>. <b>4</b> (4): 314–22. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnrc1323  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnrc1323'" tppabs="https://doi.org/10.1038%2Fnrc1323" class="external text external">10.1038/nrc1323</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15057291  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15057291'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15057291" class="external text external">15057291</a>.</cite></span></li><li id="cite_note-synth-28"> <span id="mw-reference-text-cite_note-synth-28" class="mw-reference-text"><cite id="CITEREFMullerKonneckeSmithKhetani1999" class="citation journal cs1">Muller G, Konnecke W, Smith A, Khetani V (19 March 1999). "A Concise Two-Step Synthesis of Thalidomide". <i>Organic Process Research &amp; Development</i>. <b>3</b> (2): 139–140. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fop980201b  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fop980201b'" tppabs="https://doi.org/10.1021%2Fop980201b" class="external text external">10.1021/op980201b</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFThomas2020" class="citation news cs1">Thomas, Katie (2020-03-23). <a href="javascript:if(confirm('https://www.nytimes.com/2020/03/23/health/thalidomide-survivors-usa.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2020/03/23/health/thalidomide-survivors-usa.html'" tppabs="https://www.nytimes.com/2020/03/23/health/thalidomide-survivors-usa.html" class="external text external">"The Unseen Survivors of Thalidomide Want to Be Heard"</a>. <i>The New York Times</i>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0362-4331  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0362-4331'" tppabs="https://www.worldcat.org/issn/0362-4331" class="external text external">0362-4331</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2020-03-23</span></span>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFSneader2005" class="citation book cs1">Sneader W (2005). <span class="cs1-lock-limited"><a href="javascript:if(confirm('https://archive.org/details/drugdiscoveryhis00snea  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/drugdiscoveryhis00snea'" tppabs="https://archive.org/details/drugdiscoveryhis00snea" class="external text external"><i>Drug discovery: a history</i></a></span> (Rev. and updated ed.). Chichester: Wiley. p.<span>&nbsp;</span><a href="javascript:if(confirm('https://archive.org/details/drugdiscoveryhis00snea/page/n380  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/drugdiscoveryhis00snea/page/n380'" tppabs="https://archive.org/details/drugdiscoveryhis00snea/page/n380" class="external text external">367</a>. ISBN<span>&nbsp;</span><bdi>978-0-471-89979-2</bdi>.</cite></span></li><li id="cite_note-pmid15172781-31"> <span id="mw-reference-text-cite_note-pmid15172781-31" class="mw-reference-text"><cite id="CITEREFFranksMacphersonFigg2004" class="citation journal cs1">Franks ME, Macpherson GR, Figg WD (May 2004). <a href="javascript:if(confirm('https://zenodo.org/record/1259793  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/1259793'" tppabs="https://zenodo.org/record/1259793" class="external text external">"Thalidomide"</a>. <i>Lancet</i>. <b>363</b> (9423): 1802–11. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2804%2916308-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2804%2916308-3'" tppabs="https://doi.org/10.1016%2FS0140-6736%2804%2916308-3" class="external text external">10.1016/S0140-6736(04)16308-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15172781  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15172781'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15172781" class="external text external">15172781</a>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><a href="javascript:if(confirm('https://www.grunenthal.com/about-us/history  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.grunenthal.com/about-us/history'" tppabs="https://www.grunenthal.com/about-us/history" class="external text external">Grünenthal: Where we come from</a>. Official website, undated. Retrieved 2 July 2018. See also <a href="javascript:if(confirm('http://www.contergan.grunenthal.info/thalidomid/Home_/351300028.jsp;jsessionid=D8966B9045A2EDE78D5AC41F85C93424.drp1?naviLocale=en_EN  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.contergan.grunenthal.info/thalidomid/Home_/351300028.jsp;jsessionid=D8966B9045A2EDE78D5AC41F85C93424.drp1?naviLocale=en_EN'" tppabs="http://www.contergan.grunenthal.info/thalidomid/Home_/351300028.jsp;jsessionid=D8966B9045A2EDE78D5AC41F85C93424.drp1?naviLocale=en_EN" class="external text external">Developments regarding thalidomide</a></span></li><li id="cite_note-Bombay-33"> <span id="mw-reference-text-cite_note-Bombay-33" class="mw-reference-text"><cite id="CITEREFMogheKulkarniParmar2008" class="citation journal cs1">Moghe VV, Kulkarni U, Parmar UI (2008). <a href="javascript:if(confirm('http://www.bhj.org.in/journal/2008_5003_july/download/page-472-476.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.bhj.org.in/journal/2008_5003_july/download/page-472-476.pdf'" tppabs="http://www.bhj.org.in/journal/2008_5003_july/download/page-472-476.pdf" class="external text external">"Thalidomide"</a> <span class="cs1-format">(PDF)</span>. <i>Bombay Hospital Journal</i>. Bombay: Bombay Hospital. <b>50</b> (3): 472–6.</cite></span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text">Campbell, Denis. "'Wonder drug' left babies with deformed limbs." <i>The Guardian</i>. 29 July 2009.</span></li><li id="cite_note-Chem1994-35"> <span id="mw-reference-text-cite_note-Chem1994-35" class="mw-reference-text"><cite id="CITEREFHeaton1994" class="citation book cs1">Heaton CA (1994). <i>The Chemical Industry</i>. Springer. ISBN<span>&nbsp;</span><bdi>978-0-7514-0018-2</bdi>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text">See Rouquette (1957) cited by <cite id="CITEREFLandesman-Dwyer1982" class="citation journal cs1">Landesman-Dwyer S (1982). "Maternal drinking and pregnancy outcome". <i>Applied Research in Mental Retardation</i>. <b>3</b> (3): 241–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0270-3092%2882%2990018-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0270-3092%2882%2990018-2'" tppabs="https://doi.org/10.1016%2F0270-3092%2882%2990018-2" class="external text external">10.1016/0270-3092(82)90018-2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7149705  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7149705'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7149705" class="external text external">7149705</a>.</cite></span></li><li id="cite_note-37"> <span id="mw-reference-text-cite_note-37" class="mw-reference-text"><cite id="CITEREFKelsey1967" class="citation journal cs1">Kelsey FO (1967). "Events after thalidomide". <i>Journal of Dental Research</i>. <b>46</b> (6): 1201–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F00220345670460061201  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F00220345670460061201'" tppabs="https://doi.org/10.1177%2F00220345670460061201" class="external text external">10.1177/00220345670460061201</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/5235007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/5235007'" tppabs="https://pubmed.ncbi.nlm.nih.gov/5235007" class="external text external">5235007</a>.</cite></span></li><li id="cite_note-50year-38"> <span id="mw-reference-text-cite_note-50year-38" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.youtube.com/watch?v=_NLbhOyLLMY  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.youtube.com/watch?v=_NLbhOyLLMY'" tppabs="https://www.youtube.com/watch?v=_NLbhOyLLMY" class="external text external">"Thalidomide: The Fifty Year Fight (no longer available)"</a>. BBC. 15 May 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">13 September</span> 2015</span>.</cite></span></li><li id="cite_note-oncozine.com-39"> <span id="mw-reference-text-cite_note-oncozine.com-39" class="mw-reference-text"><cite id="CITEREFHofland2013" class="citation web cs1">Hofland P (December 2013). <a href="javascript:if(confirm('https://oncozine.com/reversal-of-fortune-how-a-vilified-drug-became-a-life-saving-agent-in-the-war-against-cancer/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://oncozine.com/reversal-of-fortune-how-a-vilified-drug-became-a-life-saving-agent-in-the-war-against-cancer/'" tppabs="https://oncozine.com/reversal-of-fortune-how-a-vilified-drug-became-a-life-saving-agent-in-the-war-against-cancer/" class="external text external">"Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the "War" Against Cancer"</a>. <i>Onco'Zine</i>.</cite></span></li><li id="cite_note-VFA-40"> <span id="mw-reference-text-cite_note-VFA-40" class="mw-reference-text"><a href="javascript:if(confirm('http://www.vfa.de/de/arzneimittel-forschung/artikel-arzneimittel-forschung/teratogenitaet.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.vfa.de/de/arzneimittel-forschung/artikel-arzneimittel-forschung/teratogenitaet.html'" tppabs="http://www.vfa.de/de/arzneimittel-forschung/artikel-arzneimittel-forschung/teratogenitaet.html" class="external text external">VFA: teratogenic effects</a> 6. July 2011.</span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20090512235601/https://www.fda.gov/fdac/features/2001/201_kelsey.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090512235601/https://www.fda.gov/fdac/features/2001/201_kelsey.html'" tppabs="https://web.archive.org/web/20090512235601/https://www.fda.gov/fdac/features/2001/201_kelsey.html" class="external text external">"Report"</a>. U.S. Food and Drug Administration. 12 May 2009. Archived from <a href="javascript:if(confirm('https://www.fda.gov/fdac/features/2001/201_kelsey.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/fdac/features/2001/201_kelsey.html'" tppabs="https://www.fda.gov/fdac/features/2001/201_kelsey.html" class="external text external">the original</a> on 12 May 2009.</cite></span></li><li id="cite_note-pmid14076167-42"> <span id="mw-reference-text-cite_note-pmid14076167-42" class="mw-reference-text"><cite id="CITEREFWebb1963" class="citation journal cs1">Webb JF (November 1963). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1921912  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1921912'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1921912" class="external text external">"Canadian Thalidomide Experience"</a>. <i>Canadian Medical Association Journal</i>. <b>89</b>: 987–92. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1921912  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1921912'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1921912" class="external text external">1921912</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14076167  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14076167'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14076167" class="external text external">14076167</a>.</cite></span></li><li id="cite_note-Silverman-43"> <span id="mw-reference-text-cite_note-Silverman-43" class="mw-reference-text"><cite id="CITEREFSilverman2002" class="citation journal cs1">Silverman WA (August 2002). "The schizophrenic career of a "monster drug<span class="cs1-kern-right">"</span>". <i>Pediatrics</i>. <b>110</b> (2 Pt 1): 404–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1542%2Fpeds.110.2.404  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1542%2Fpeds.110.2.404'" tppabs="https://doi.org/10.1542%2Fpeds.110.2.404" class="external text external">10.1542/peds.110.2.404</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12165600  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12165600'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12165600" class="external text external">12165600</a>.</cite></span></li><li id="cite_note-44"> <span id="mw-reference-text-cite_note-44" class="mw-reference-text"><cite id="CITEREFCastillaAshton-ProllaBarreda-MejiaBrunoni1996" class="citation journal cs1">Castilla EE, Ashton-Prolla P, Barreda-Mejia E, Brunoni D, Cavalcanti DP, Correa-Neto J, Delgadillo JL, Dutra MG, Felix T, Giraldo A, Juarez N, Lopez-Camelo JS, Nazer J, Orioli IM, Paz JE, Pessoto MA, Pina-Neto JM, Quadrelli R, Rittler M, Rueda S, Saltos M, Sánchez O, Schüler L (December 1996). "Thalidomide, a current teratogen in South America". <i>Teratology</i>. <b>54</b> (6): 273–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F%28SICI%291096-9926%28199702%2955%3A2%3C156%3A%3AAID-TERA6%3E3.0.CO%3B2-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F%28SICI%291096-9926%28199702%2955%3A2%3C156%3A%3AAID-TERA6%3E3.0.CO%3B2-1'" tppabs="https://doi.org/10.1002%2F%28SICI%291096-9926%28199702%2955%3A2%3C156%3A%3AAID-TERA6%3E3.0.CO%3B2-1" class="external text external">10.1002/(SICI)1096-9926(199702)55:2<span>&lt;</span>156::AID-TERA6<span>&gt;</span>3.0.CO;2-1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9098920  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9098920'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9098920" class="external text external">9098920</a>.</cite></span></li><li id="cite_note-45"> <span id="mw-reference-text-cite_note-45" class="mw-reference-text"><cite id="CITEREFPaumgarttenChahoud2006" class="citation journal cs1">Paumgartten FJ, Chahoud I (July 2006). "Thalidomide embryopathy cases in Brazil after 1965". <i>Reproductive Toxicology</i>. <b>22</b> (1): 1–2. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.reprotox.2005.11.007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.reprotox.2005.11.007'" tppabs="https://doi.org/10.1016%2Fj.reprotox.2005.11.007" class="external text external">10.1016/j.reprotox.2005.11.007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16427249  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16427249'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16427249" class="external text external">16427249</a>.</cite></span></li><li id="cite_note-46"> <span id="mw-reference-text-cite_note-46" class="mw-reference-text"><cite id="CITEREFBraziliense2006" class="citation journal cs1">Braziliense C (January 2006). <a href="javascript:if(confirm('https://web.archive.org/web/20120313095445/http://www.saude.df.gov.br/003/00301009.asp?ttCD_CHAVE=31041  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120313095445/http://www.saude.df.gov.br/003/00301009.asp?ttCD_CHAVE=31041'" tppabs="https://web.archive.org/web/20120313095445/http://www.saude.df.gov.br/003/00301009.asp?ttCD_CHAVE=31041" class="external text external">"Talidomida volta a assustar"</a> <span>[</span>Thalidomide again scare<span>]</span> (in Portuguese). Archived from <a href="javascript:if(confirm('http://www.saude.df.gov.br/003/00301009.asp?ttCD_CHAVE=31041  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.saude.df.gov.br/003/00301009.asp?ttCD_CHAVE=31041'" tppabs="http://www.saude.df.gov.br/003/00301009.asp?ttCD_CHAVE=31041" class="external text external">the original</a> on 13 March 2012.</cite><span> </span><span class="cs1-hidden-error error citation-comment">Cite journal requires <code class="cs1-code"><span>|</span>journal=</code> (help)</span></span></li><li id="cite_note-47"> <span id="mw-reference-text-cite_note-47" class="mw-reference-text"><cite id="CITEREFCrawford2013" class="citation news cs1">Crawford A (23 July 2013). <a href="javascript:if(confirm('https://www.bbc.com/news/magazine-23418102  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.bbc.com/news/magazine-23418102'" tppabs="https://www.bbc.com/news/magazine-23418102" class="external text external">"Brazil's new generation of Thalidomide babies"</a>. <i>BBC News</i>.</cite></span></li><li id="cite_note-nyt-fda-48"> <span id="mw-reference-text-cite_note-nyt-fda-48" class="mw-reference-text"><cite id="CITEREFStolberg1998" class="citation news cs1">Stolberg SG (17 July 1998). <a href="javascript:if(confirm('https://www.nytimes.com/1998/07/17/us/thalidomide-approved-to-treat-leprosy-with-other-uses-seen.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/1998/07/17/us/thalidomide-approved-to-treat-leprosy-with-other-uses-seen.html'" tppabs="https://www.nytimes.com/1998/07/17/us/thalidomide-approved-to-treat-leprosy-with-other-uses-seen.html" class="external text external">"Thalidomide Approved to Treat Leprosy, With Other Uses Seen"</a>. <i>New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">8 January</span> 2012</span>.</cite></span></li><li id="cite_note-49"> <span id="mw-reference-text-cite_note-49" class="mw-reference-text"><cite id="CITEREFAnon" class="citation web cs1">Anon. <a href="javascript:if(confirm('http://www.who.int/lep/research/thalidomide/en/index.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.who.int/lep/research/thalidomide/en/index.html'" tppabs="http://www.who.int/lep/research/thalidomide/en/index.html" class="external text external">"Use of thalidomide in leprosy"</a>. <i>WHO:leprosy elimination</i>. WHO<span class="reference-accessdate">. Retrieved <span class="nowrap">22 April</span> 2010</span>.</cite></span></li><li id="cite_note-Kyle-50"> <span id="mw-reference-text-cite_note-Kyle-50" class="mw-reference-text"><cite id="CITEREFKyleRajkumar2008" class="citation journal cs1">Kyle RA, Rajkumar SV (March 2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265446  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265446'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265446" class="external text external">"Multiple myeloma"</a>. <i>Blood</i>. <b>111</b> (6): 2962–72. doi:<a href="javascript:if(confirm('https://doi.org/10.1182%2Fblood-2007-10-078022  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1182%2Fblood-2007-10-078022'" tppabs="https://doi.org/10.1182%2Fblood-2007-10-078022" class="external text external">10.1182/blood-2007-10-078022</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265446  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265446'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265446" class="external text external">2265446</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18332230  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18332230'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18332230" class="external text external">18332230</a>.</cite></span></li><li id="cite_note-NASbio-51"> <span id="mw-reference-text-cite_note-NASbio-51" class="mw-reference-text"><cite id="CITEREFDonahoe2014" class="citation web cs1">Donahoe PK (2014). <a href="javascript:if(confirm('http://www.nasonline.org/publications/biographical-memoirs/memoir-pdfs/folkman-judah.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nasonline.org/publications/biographical-memoirs/memoir-pdfs/folkman-judah.pdf'" tppabs="http://www.nasonline.org/publications/biographical-memoirs/memoir-pdfs/folkman-judah.pdf" class="external text external">"Judah Folkman: 1933–2008. A Biographical Memoir"</a> <span class="cs1-format">(PDF)</span>. National Academy of Sciences.</cite></span></li><li id="cite_note-Beilenberg-52"> <span id="mw-reference-text-cite_note-Beilenberg-52" class="mw-reference-text"><cite id="CITEREFBielenbergD'Amore2008" class="citation journal cs1">Bielenberg DR, D'Amore PA (2008). "Judah Folkman's contribution to the inhibition of angiogenesis". <i>Lymphatic Research and Biology</i>. <b>6</b> (3–4): 203–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1089%2Flrb.2008.1016  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1089%2Flrb.2008.1016'" tppabs="https://doi.org/10.1089%2Flrb.2008.1016" class="external text external">10.1089/lrb.2008.1016</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19093793  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19093793'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19093793" class="external text external">19093793</a>.</cite></span></li><li id="cite_note-Folkman-53"> <span id="mw-reference-text-cite_note-Folkman-53" class="mw-reference-text"><cite id="CITEREFFolkman2001" class="citation journal cs1">Folkman J (December 2001). "Angiogenesis-dependent diseases". <i>Seminars in Oncology</i>. <b>28</b> (6): 536–42. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0093-7754%2801%2990021-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0093-7754%2801%2990021-1'" tppabs="https://doi.org/10.1016%2Fs0093-7754%2801%2990021-1" class="external text external">10.1016/s0093-7754(01)90021-1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11740806  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11740806'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11740806" class="external text external">11740806</a>.</cite></span></li><li id="cite_note-54"> <span id="mw-reference-text-cite_note-54" class="mw-reference-text"><cite id="CITEREFRibatti2008" class="citation journal cs1">Ribatti D (2008). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268723  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268723'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268723" class="external text external">"Judah Folkman, a pioneer in the study of angiogenesis"</a>. <i>Angiogenesis</i>. <b>11</b> (1): 3–10. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs10456-008-9092-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs10456-008-9092-6'" tppabs="https://doi.org/10.1007%2Fs10456-008-9092-6" class="external text external">10.1007/s10456-008-9092-6</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268723  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268723'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268723" class="external text external">2268723</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18247146  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18247146'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18247146" class="external text external">18247146</a>.</cite></span></li><li id="cite_note-55"> <span id="mw-reference-text-cite_note-55" class="mw-reference-text"><cite id="CITEREFD'AmatoLoughnanFlynnFolkman1994" class="citation journal cs1">D'Amato RJ, Loughnan MS, Flynn E, Folkman J (April 1994). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC43727  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC43727'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC43727" class="external text external">"Thalidomide is an inhibitor of angiogenesis"</a>. <i>Proc Natl Acad Sci U S A</i>. <b>91</b> (9): 4082–4085. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/1994PNAS...91.4082D  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/1994PNAS...91.4082D'" tppabs="https://ui.adsabs.harvard.edu/abs/1994PNAS...91.4082D" class="external text external">1994PNAS...91.4082D</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.91.9.4082  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.91.9.4082'" tppabs="https://doi.org/10.1073%2Fpnas.91.9.4082" class="external text external">10.1073/pnas.91.9.4082</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC43727  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC43727'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC43727" class="external text external">43727</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7513432  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7513432'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7513432" class="external text external">7513432</a>.</cite></span></li><li id="cite_note-56"> <span id="mw-reference-text-cite_note-56" class="mw-reference-text"><cite id="CITEREFVerheulPanigrahyYuanD'Amato1999" class="citation journal cs1">Verheul HM, Panigrahy D, Yuan J, D'Amato RJ (January 1999). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362163  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362163'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362163" class="external text external">"Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits"</a>. <i>Br J Cancer</i>. <b>79</b> (1): 114–118. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fsj.bjc.6690020  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fsj.bjc.6690020'" tppabs="https://doi.org/10.1038%2Fsj.bjc.6690020" class="external text external">10.1038/sj.bjc.6690020</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362163  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362163'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362163" class="external text external">2362163</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10408702  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10408702'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10408702" class="external text external">10408702</a>.</cite></span></li><li id="cite_note-nejm-myeloma-57"> <span id="mw-reference-text-cite_note-nejm-myeloma-57" class="mw-reference-text"><cite id="CITEREFSinghalMehtaDesikanAyers1999" class="citation journal cs1">Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B (November 1999). "Antitumor activity of thalidomide in refractory multiple myeloma". <i>The New England Journal of Medicine</i>. <b>341</b> (21): 1565–71. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJM199911183412102  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJM199911183412102'" tppabs="https://doi.org/10.1056%2FNEJM199911183412102" class="external text external">10.1056/NEJM199911183412102</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10564685  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10564685'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10564685" class="external text external">10564685</a>.</cite></span></li><li id="cite_note-58"> <span id="mw-reference-text-cite_note-58" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.cancer.gov/cancertopics/druginfo/fda-thalidomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancer.gov/cancertopics/druginfo/fda-thalidomide'" tppabs="http://www.cancer.gov/cancertopics/druginfo/fda-thalidomide" class="external text external">"FDA Approval for Thalidomide"</a>. National Cancer Institute<span class="reference-accessdate">. Retrieved <span class="nowrap">8 January</span> 2012</span>.</cite></span></li><li id="cite_note-Bren-59"> <span id="mw-reference-text-cite_note-Bren-59" class="mw-reference-text"><cite id="CITEREFBren_L2001" class="citation news cs1">Bren L (28 February 2001). <a href="javascript:if(confirm('http://permanent.access.gpo.gov/lps1609/www.fda.gov/fdac/features/2001/201_kelsey.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://permanent.access.gpo.gov/lps1609/www.fda.gov/fdac/features/2001/201_kelsey.html'" tppabs="http://permanent.access.gpo.gov/lps1609/www.fda.gov/fdac/features/2001/201_kelsey.html" class="external text external">"Frances Oldham Kelsey: FDA Medical Reviewer Leaves Her Mark on History"</a>. <i>FDA Consumer</i>. U.S. Food and Drug Administration<span class="reference-accessdate">. Retrieved <span class="nowrap">23 December</span> 2009</span>.</cite></span></li><li id="cite_note-nyt-answers-60"> <span id="mw-reference-text-cite_note-nyt-answers-60" class="mw-reference-text"><cite id="CITEREFZimmer_C2010" class="citation news cs1">Zimmer C (15 March 2010). <a href="javascript:if(confirm('https://www.nytimes.com/2010/03/16/science/16limb.html?ref=science&pagewanted=all  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nytimes.com/2010/03/16/science/16limb.html?ref=science&pagewanted=all'" tppabs="https://www.nytimes.com/2010/03/16/science/16limb.html?ref=science&pagewanted=all" class="external text external">"Answers Begin to Emerge on How Thalidomide Caused Defects"</a>. <i>New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2010-03-21</span></span>. <q>As they report in the current issue of Science, a protein known as cereblon latched on tightly to the thalidomide</q></cite></span></li><li id="cite_note-61"> <span id="mw-reference-text-cite_note-61" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20110929135332/http://www.history.ca/ontv/titledetails.aspx?titleid=21267  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110929135332/http://www.history.ca/ontv/titledetails.aspx?titleid=21267'" tppabs="https://web.archive.org/web/20110929135332/http://www.history.ca/ontv/titledetails.aspx?titleid=21267" class="external text external">"Turning Points of History–Prescription for Disaster"</a>. History Television. Archived from <a href="javascript:if(confirm('http://www.history.ca/ontv/titledetails.aspx?titleid=21267  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.history.ca/ontv/titledetails.aspx?titleid=21267'" tppabs="http://www.history.ca/ontv/titledetails.aspx?titleid=21267" class="external text external">the original</a> on September 29, 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">24 February</span> 2010</span>.</cite></span></li><li id="cite_note-Tamplin-62"> <span id="mw-reference-text-cite_note-Tamplin-62" class="mw-reference-text"><cite id="CITEREFTamplin2015" class="citation news cs1">Tamplin H (12 June 2015). <a href="javascript:if(confirm('http://www.midsussextimes.co.uk/news/local/mid-sussex-residents-honoured-by-queen-1-6795898  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.midsussextimes.co.uk/news/local/mid-sussex-residents-honoured-by-queen-1-6795898'" tppabs="http://www.midsussextimes.co.uk/news/local/mid-sussex-residents-honoured-by-queen-1-6795898" class="external text external">"Mid Sussex residents honoured by Queen"</a>. <i>Mid Sussex Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">27 December</span> 2015</span>.</cite></span></li><li id="cite_note-63"> <span id="mw-reference-text-cite_note-63" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20120306201745/https://www.portlandphoenix.com/archive/music/02/04/19/classical_Orpheus.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120306201745/https://www.portlandphoenix.com/archive/music/02/04/19/classical_Orpheus.html'" tppabs="https://web.archive.org/web/20120306201745/https://www.portlandphoenix.com/archive/music/02/04/19/classical_Orpheus.html" class="external text external">"Orpheus lives: A small good thing in Quastoff"</a>. <i>The Portland Phoenix</i>. April 19, 2002. Archived from <a href="javascript:if(confirm('http://www.portlandphoenix.com/archive/music/02/04/19/classical_Orpheus.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.portlandphoenix.com/archive/music/02/04/19/classical_Orpheus.html'" tppabs="http://www.portlandphoenix.com/archive/music/02/04/19/classical_Orpheus.html" class="external text external">the original</a> on 6 March 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">6 June</span> 2013</span>.</cite></span></li><li id="cite_note-64"> <span id="mw-reference-text-cite_note-64" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.imdb.com/title/tt1266093/releaseinfo  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.imdb.com/title/tt1266093/releaseinfo'" tppabs="https://www.imdb.com/title/tt1266093/releaseinfo" class="external text external">"NoBody's Perfect (2008): Release Info"</a>. IMDB<span class="reference-accessdate">. Retrieved <span class="nowrap">6 June</span> 2013</span>.</cite></span></li><li id="cite_note-65"> <span id="mw-reference-text-cite_note-65" class="mw-reference-text"><cite id="CITEREFBrussatBrussat" class="citation web cs1">Brussat F, Brussat MA. <a href="javascript:if(confirm('http://www.spiritualityandpractice.com/films/films.php?id=19559  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.spiritualityandpractice.com/films/films.php?id=19559'" tppabs="http://www.spiritualityandpractice.com/films/films.php?id=19559" class="external text external">"Film Review: NoBody's Perfect"</a>. Spirituality &amp; Practice<span class="reference-accessdate">. Retrieved <span class="nowrap">6 June</span> 2013</span>.</cite></span></li><li id="cite_note-66"> <span id="mw-reference-text-cite_note-66" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.uwindsor.ca/dailynews/2016-06-07/outstanding-eight-receive-honorary-doctorates-convocation  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.uwindsor.ca/dailynews/2016-06-07/outstanding-eight-receive-honorary-doctorates-convocation'" tppabs="http://www.uwindsor.ca/dailynews/2016-06-07/outstanding-eight-receive-honorary-doctorates-convocation" class="external text external">"Outstanding eight to receive honorary doctorates at Convocation"</a>. <i>Daily News</i>. Windsor, Ontario, Canada: University of Windsor. 9 June 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">6 March</span> 2017</span>.</cite></span></li><li id="cite_note-67"> <span id="mw-reference-text-cite_note-67" class="mw-reference-text"><cite id="CITEREFMitchellSnyder2005" class="citation journal cs1">Mitchell D, Snyder S (June 2005). <a href="javascript:if(confirm('http://www.dsq-sds.org/article/view/575/752  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.dsq-sds.org/article/view/575/752'" tppabs="http://www.dsq-sds.org/article/view/575/752" class="external text external">"Exploitations of embodiment: Born Freak and the academic bally plank"</a>. <i>Disability Studies Quarterly</i>. <b>25</b> (3). doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.18061%2Fdsq.v25i3.575  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.18061%2Fdsq.v25i3.575'" tppabs="https://doi.org/10.18061%2Fdsq.v25i3.575" class="external text external">10.18061/dsq.v25i3.575</a></span>.</cite></span></li><li id="cite_note-68"> <span id="mw-reference-text-cite_note-68" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fda.gov/Drugs/NewsEvents/ucm320924.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/NewsEvents/ucm320924.htm'" tppabs="https://www.fda.gov/Drugs/NewsEvents/ucm320924.htm" class="external text external">"50 Years: The Kefauver-Harris Amendments"</a>. Food and Drug Administration (United States)<span class="reference-accessdate">. Retrieved <span class="nowrap">6 June</span> 2013</span>.</cite></span></li><li id="cite_note-69"> <span id="mw-reference-text-cite_note-69" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20131203020225/http://www.crncc.nihr.ac.uk/workforce_development/learning_and_development/gcp/gcp_resource/research_standards/history/thalidomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20131203020225/http://www.crncc.nihr.ac.uk/workforce_development/learning_and_development/gcp/gcp_resource/research_standards/history/thalidomide'" tppabs="https://web.archive.org/web/20131203020225/http://www.crncc.nihr.ac.uk/workforce_development/learning_and_development/gcp/gcp_resource/research_standards/history/thalidomide" class="external text external">"Thalidomide"</a>. National Health Service (England). Archived from <a href="javascript:if(confirm('http://www.crncc.nihr.ac.uk/workforce_development/learning_and_development/gcp/gcp_resource/research_standards/history/thalidomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.crncc.nihr.ac.uk/workforce_development/learning_and_development/gcp/gcp_resource/research_standards/history/thalidomide'" tppabs="http://www.crncc.nihr.ac.uk/workforce_development/learning_and_development/gcp/gcp_resource/research_standards/history/thalidomide" class="external text external">the original</a> on 3 December 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">6 June</span> 2013</span>.</cite></span></li><li id="cite_note-70"> <span id="mw-reference-text-cite_note-70" class="mw-reference-text"><cite id="CITEREFConroyMcIntyreChoonara1999" class="citation journal cs1">Conroy S, McIntyre J, Choonara I (March 1999). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720896  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720896'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720896" class="external text external">"Unlicensed and off label drug use in neonates"</a>. <i>Archives of Disease in Childhood: Fetal and Neonatal Edition</i>. <b>80</b> (2): F142–4, discussion F144–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Ffn.80.2.F142  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Ffn.80.2.F142'" tppabs="https://doi.org/10.1136%2Ffn.80.2.F142" class="external text external">10.1136/fn.80.2.F142</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720896  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720896'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1720896" class="external text external">1720896</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10325794  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10325794'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10325794" class="external text external">10325794</a>.</cite></span></li><li id="cite_note-71"> <span id="mw-reference-text-cite_note-71" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20111014114005/https://www.rpharms.com/museum-pdfs/e3a-thalidomide-and-its-aftermath-2011.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20111014114005/https://www.rpharms.com/museum-pdfs/e3a-thalidomide-and-its-aftermath-2011.pdf'" tppabs="https://web.archive.org/web/20111014114005/https://www.rpharms.com/museum-pdfs/e3a-thalidomide-and-its-aftermath-2011.pdf" class="external text external">"The evolution of pharmacy, Theme E, Level 3 Thalidomide and its aftermath"</a> <span class="cs1-format">(PDF)</span>. Royal Pharmaceutical Society. 2011. Archived from <a href="javascript:if(confirm('https://www.rpharms.com/museum-pdfs/e3a-thalidomide-and-its-aftermath-2011.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.rpharms.com/museum-pdfs/e3a-thalidomide-and-its-aftermath-2011.pdf'" tppabs="https://www.rpharms.com/museum-pdfs/e3a-thalidomide-and-its-aftermath-2011.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 14 October 2011.</cite></span></li><li id="cite_note-Wadman_e0210222-72"> <span id="mw-reference-text-cite_note-Wadman_e0210222-72" class="mw-reference-text"><cite id="CITEREFNewbronnerGlendinningAtkinWadman2019" class="citation journal cs1">Newbronner E, Glendinning C, Atkin K, Wadman R (2019-01-16). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334953  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334953'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334953" class="external text external">"The health and quality of life of Thalidomide survivors as they age - Evidence from a UK survey"</a>. <i>PLOS ONE</i>. <b>14</b> (1): e0210222. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pone.0210222  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pone.0210222'" tppabs="https://doi.org/10.1371%2Fjournal.pone.0210222" class="external text external">10.1371/journal.pone.0210222</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334953  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334953'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334953" class="external text external">6334953</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/30650111  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/30650111'" tppabs="https://pubmed.ncbi.nlm.nih.gov/30650111" class="external text external">30650111</a>.</cite></span></li><li id="cite_note-40_years_later:_the_health_related-73"> <span id="mw-reference-text-cite_note-40_years_later:_the_health_related-73" class="mw-reference-text"><cite id="CITEREFNippertEdlerSchmidt-Herterich2002" class="citation journal cs1">Nippert I, Edler B, Schmidt-Herterich C (2002). "40 years later: the health related quality of life of women affected by thalidomide". <i>Community Genetics</i>. <b>5</b> (4): 209–16. doi:<a href="javascript:if(confirm('https://doi.org/10.1159%2F000066691  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1159%2F000066691'" tppabs="https://doi.org/10.1159%2F000066691" class="external text external">10.1159/000066691</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14960874  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14960874'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14960874" class="external text external">14960874</a>.</cite></span></li><li id="cite_note-pmid10447943-74"> <span id="mw-reference-text-cite_note-pmid10447943-74" class="mw-reference-text"><cite id="CITEREFShahSwartzPapathanassiuTreston1999" class="citation journal cs1">Shah JH, Swartz GM, Papathanassiu AE, Treston AM, Fogler WE, Madsen JW, Green SJ (August 1999). "Synthesis and enantiomeric separation of 2-phthalimidino-glutaric acid analogues: potent inhibitors of tumor metastasis". <i>Journal of Medicinal Chemistry</i>. <b>42</b> (16): 3014–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjm990083y  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjm990083y'" tppabs="https://doi.org/10.1021%2Fjm990083y" class="external text external">10.1021/jm990083y</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10447943  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10447943'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10447943" class="external text external">10447943</a>.</cite></span></li><li id="cite_note-pmid11740816-75"> <span id="mw-reference-text-cite_note-pmid11740816-75" class="mw-reference-text"><cite id="CITEREFD'AmatoLentzschAndersonRogers2001" class="citation journal cs1">D'Amato RJ, Lentzsch S, Anderson KC, Rogers MS (December 2001). "Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma". <i>Seminars in Oncology</i>. <b>28</b> (6): 597–601. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0093-7754%2801%2990031-4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0093-7754%2801%2990031-4'" tppabs="https://doi.org/10.1016%2FS0093-7754%2801%2990031-4" class="external text external">10.1016/S0093-7754(01)90031-4</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11740816  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11740816'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11740816" class="external text external">11740816</a>.</cite></span></li><li id="cite_note-76"> <span id="mw-reference-text-cite_note-76" class="mw-reference-text"><cite id="CITEREFRao2007" class="citation journal cs1">Rao KV (September 2007). "Lenalidomide in the treatment of multiple myeloma". <i>American Journal of Health-System Pharmacy</i>. <b>64</b> (17): 1799–807. doi:<a href="javascript:if(confirm('https://doi.org/10.2146%2Fajhp070029  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2146%2Fajhp070029'" tppabs="https://doi.org/10.2146%2Fajhp070029" class="external text external">10.2146/ajhp070029</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17724360  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17724360'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17724360" class="external text external">17724360</a>.</cite></span></li><li id="cite_note-77"> <span id="mw-reference-text-cite_note-77" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://clinicaltrials.gov/ct/search?term=pomalidomide&submit=Search  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://clinicaltrials.gov/ct/search?term=pomalidomide&submit=Search'" tppabs="http://clinicaltrials.gov/ct/search?term=pomalidomide&submit=Search" class="external text external">"Search of: pomalidomide"</a>. Clinicaltrials.gov<span class="reference-accessdate">. Retrieved <span class="nowrap">1 September</span> 2012</span>.</cite></span></li><li id="cite_note-78"> <span id="mw-reference-text-cite_note-78" class="mw-reference-text"><cite id="CITEREFRaghupathyBillett2009" class="citation journal cs1">Raghupathy R, Billett HH (March 2009). "Promising therapies in sickle cell disease". <i>Cardiovascular &amp; Hematological Disorders Drug Targets</i>. <b>9</b> (1): 1–8. doi:<a href="javascript:if(confirm('https://doi.org/10.2174%2F187152909787581354  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2174%2F187152909787581354'" tppabs="https://doi.org/10.2174%2F187152909787581354" class="external text external">10.2174/187152909787581354</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19275572  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19275572'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19275572" class="external text external">19275572</a>.</cite></span></li><li id="cite_note-P1-79"> <span id="mw-reference-text-cite_note-P1-79" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.myelomabeacon.com/news/2013/02/08/pomalyst-pomalidomide-fda-approval-multiple-myeloma/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.myelomabeacon.com/news/2013/02/08/pomalyst-pomalidomide-fda-approval-multiple-myeloma/'" tppabs="http://www.myelomabeacon.com/news/2013/02/08/pomalyst-pomalidomide-fda-approval-multiple-myeloma/" class="external text external">"Pomalyst (Pomalidomide) Approved By FDA For Relapsed And Refractory Multiple Myeloma"</a>. The Myeloma Beacon<span class="reference-accessdate">. Retrieved <span class="nowrap">2013-08-10</span></span>.</cite></span></li><li id="cite_note-P2-80"> <span id="mw-reference-text-cite_note-P2-80" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.myelomabeacon.com/news/2013/08/09/pomalidomide-imnovid-pomalyst-europe-ema-approval-multiple-myeloma/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.myelomabeacon.com/news/2013/08/09/pomalidomide-imnovid-pomalyst-europe-ema-approval-multiple-myeloma/'" tppabs="http://www.myelomabeacon.com/news/2013/08/09/pomalidomide-imnovid-pomalyst-europe-ema-approval-multiple-myeloma/" class="external text external">"Pomalidomide Approved In Europe For Relapsed And Refractory Multiple Myeloma"</a>. The Myeloma Beacon<span class="reference-accessdate">. Retrieved <span class="nowrap">2013-08-10</span></span>.</cite></span></li><li id="cite_note-81"> <span id="mw-reference-text-cite_note-81" class="mw-reference-text"><cite id="CITEREFSrinivasanAkobeng2009" class="citation journal cs1">Srinivasan R, Akobeng AK (April 2009). "Thalidomide and thalidomide analogues for induction of remission in Crohn's disease". <i>The Cochrane Database of Systematic Reviews</i> (2): CD007350. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD007350.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD007350.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD007350.pub2" class="external text external">10.1002/14651858.CD007350.pub2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19370684  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19370684'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19370684" class="external text external">19370684</a>.</cite></span></li><li id="cite_note-82"> <span id="mw-reference-text-cite_note-82" class="mw-reference-text"><cite id="CITEREFAkobengStokkers2009" class="citation journal cs1">Akobeng AK, Stokkers PC (April 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207562  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207562'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207562" class="external text external">"Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease"</a>. <i>The Cochrane Database of Systematic Reviews</i> (2): CD007351. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD007351.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD007351.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD007351.pub2" class="external text external">10.1002/14651858.CD007351.pub2</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207562  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207562'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207562" class="external text external">7207562</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19370685  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19370685'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19370685" class="external text external">19370685</a>.</cite></span></li><li id="cite_note-83"> <span id="mw-reference-text-cite_note-83" class="mw-reference-text"><cite id="CITEREFRoseFishmanSparano2013" class="citation web cs1">Rose LJ, Fishman AD, Sparano JA (11 March 2013).  Talavera F, McKenna R, Harris JE (eds.). <a href="javascript:if(confirm('http://emedicine.medscape.com/article/279734-treatment  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://emedicine.medscape.com/article/279734-treatment#showall'" tppabs="http://emedicine.medscape.com/article/279734-treatment#showall" class="external text external">"Kaposi Sarcoma Treatment &amp; Management"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">19 January</span> 2014</span>.</cite></span></li><li id="cite_note-84"> <span id="mw-reference-text-cite_note-84" class="mw-reference-text"><cite id="CITEREFGordonTrebbleEllisDuncan2005" class="citation journal cs1">Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, Goggin PM (April 2005). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774430  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774430'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774430" class="external text external">"Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial"</a>. <i>Gut</i>. <b>54</b> (4): 540–5. doi:<a href="javascript:if(confirm('https://doi.org/10.1136%2Fgut.2004.047563  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1136%2Fgut.2004.047563'" tppabs="https://doi.org/10.1136%2Fgut.2004.047563" class="external text external">10.1136/gut.2004.047563</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774430  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774430'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774430" class="external text external">1774430</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15753541  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15753541'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15753541" class="external text external">15753541</a>.</cite></span></li><li id="cite_note-85"> <span id="mw-reference-text-cite_note-85" class="mw-reference-text"><cite id="CITEREFSharpstoneRowbottomFrancisTovey1997" class="citation journal cs1">Sharpstone D, Rowbottom A, Francis N, Tovey G, Ellis D, Barrett M, Gazzard B (June 1997). "Thalidomide: a novel therapy for microsporidiosis". <i>Gastroenterology</i>. <b>112</b> (6): 1823–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1053%2Fgast.1997.v112.pm9178672  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1053%2Fgast.1997.v112.pm9178672'" tppabs="https://doi.org/10.1053%2Fgast.1997.v112.pm9178672" class="external text external">10.1053/gast.1997.v112.pm9178672</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9178672  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9178672'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9178672" class="external text external">9178672</a>.</cite></span></li><li id="cite_note-86"> <span id="mw-reference-text-cite_note-86" class="mw-reference-text"><cite id="CITEREFTunioHashmiQayyumNaimatullah2012" class="citation journal cs1">Tunio MA, Hashmi A, Qayyum A, Naimatullah N, Masood R (September 2012). "Low-dose thalidomide in patients with metastatic renal cell carcinoma". <i>JPMA. The Journal of the Pakistan Medical Association</i>. <b>62</b> (9): 876–9. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23139966  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23139966'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23139966" class="external text external">23139966</a>.</cite></span></li><li id="cite_note-87"> <span id="mw-reference-text-cite_note-87" class="mw-reference-text"><cite id="CITEREFHamuryudanMatSaipOzyazgan1998" class="citation journal cs1">Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H (March 1998). "Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial". <i>Annals of Internal Medicine</i>. <b>128</b> (6): 443–50. doi:<a href="javascript:if(confirm('https://doi.org/10.7326%2F0003-4819-128-6-199803150-00004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7326%2F0003-4819-128-6-199803150-00004'" tppabs="https://doi.org/10.7326%2F0003-4819-128-6-199803150-00004" class="external text external">10.7326/0003-4819-128-6-199803150-00004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9499327  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9499327'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9499327" class="external text external">9499327</a>.</cite></span></li><li id="cite_note-88"> <span id="mw-reference-text-cite_note-88" class="mw-reference-text"><cite id="CITEREFWallisHafner2015" class="citation journal cs1">Wallis RS, Hafner R (April 2015). "Advancing host-directed therapy for tuberculosis". <i>Nature Reviews. Immunology</i>. <b>15</b> (4): 255–63. doi:<a href="javascript:if(confirm('https://doi.org/10.1038%2Fnri3813  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1038%2Fnri3813'" tppabs="https://doi.org/10.1038%2Fnri3813" class="external text external">10.1038/nri3813</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25765201  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25765201'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25765201" class="external text external">25765201</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<style data-mw-deduplicate="TemplateStyles:r886047268">.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{list-style-type:none;margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>dd{margin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none}.mw-parser-output .refbegin-100{font-size:100%}</style><div class="refbegin reflist   " style="">
<ul><li><cite id="CITEREFStephensBrynner2001" class="citation book cs1">Stephens T, Brynner R (2001-12-24). <span class="cs1-lock-registration"><a href="javascript:if(confirm('https://archive.org/details/darkremedyimpact00step  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://archive.org/details/darkremedyimpact00step'" tppabs="https://archive.org/details/darkremedyimpact00step" class="external text external"><i>Dark Remedy: The Impact of Thalidomide and Its Revival as a Vital Medicine</i></a></span>. Perseus Books. ISBN<span>&nbsp;</span><bdi>978-0-7382-0590-8</bdi>.</cite></li>
<li><cite id="CITEREFKnightleyEvans1979" class="citation book cs1">Knightley P, Evans H (1979). <i>Suffer The Children: The Story of Thalidomide</i>. New York: The Viking Press. ISBN<span>&nbsp;</span><bdi>978-0-670-68114-3</bdi>.</cite></li></ul>
</div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('http://www.who.int/entity/medicines/publications/newsletter/en/news2003_2.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.who.int/entity/medicines/publications/newsletter/en/news2003_2.pdf'" tppabs="http://www.who.int/entity/medicines/publications/newsletter/en/news2003_2.pdf" class="external text external">WHO Pharmaceuticals Newsletter No. 2, 2003 – See page 11, Feature Article</a></li>
<li><a href="javascript:if(confirm('http://www.cbc.ca/archives/topic/thalidomide-bitter-pills-broken-promises  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cbc.ca/archives/topic/thalidomide-bitter-pills-broken-promises'" tppabs="http://www.cbc.ca/archives/topic/thalidomide-bitter-pills-broken-promises" class="external text external">CBC Digital Archives<span>&nbsp;</span>– Thalidomide: Bitter Pills, Broken Promises</a></li>
<li><a href="javascript:if(confirm('http://theconversation.com/remind-me-again-what-is-thalidomide-and-how-did-it-cause-so-much-harm-46847  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://theconversation.com/remind-me-again-what-is-thalidomide-and-how-did-it-cause-so-much-harm-46847'" tppabs="http://theconversation.com/remind-me-again-what-is-thalidomide-and-how-did-it-cause-so-much-harm-46847" class="external text external">Remind me again, what is thalidomide and how did it cause so much harm?</a>. The Conversation, 7 December 2015</li>
<li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/thalidomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/thalidomide'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/thalidomide" class="external text external">"Thalidomide"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Antiangiogenics" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antiangiogenics" style="font-size:114%;margin:0 4em">Antiangiogenics</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Endogenous</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Angiopoietin 2</li>
<li>angiostatin</li>
<li><span class="new">canstatin</span></li>
<li>calreticulin</li>
<li>endostatin</li>
<li>IFN-α</li>
<li>IFN-β</li>
<li>IFN-γ</li>
<li>CXCL10</li>
<li>IL-4</li>
<li>IL-12</li>
<li>IL-18</li>
<li>maspin</li>
<li>Meth-1</li>
<li>Meth-2</li>
<li>osteopontin</li>
<li>platelet factor-4</li>
<li>prolactin</li>
<li><span class="new">proliferin-related protein</span></li>
<li><a href="Thrombin.htm" tppabs="https://ptable.com/wiki/compounds/A/Prothrombin" title="Prothrombin" class="mw-redirect">prothrombin</a> (kringle domain-2)</li>
<li>antithrombin III fragment</li>
<li>SPARC</li>
<li>Thrombospondin 1</li>
<li>TIMP</li>
<li>vasostatin</li>
<li>VEGI</li>
<li>soluble VEGFR-1</li>
<li>NRP-1</li>
<li>CDAI</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Exogenous</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="2-Methoxyestradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/2-Methoxyestradiol" title="2-Methoxyestradiol">2-Methoxyestradiol</a></li>
<li>α<sub>V</sub>β<sub>3</sub> inhibitors</li>
<li><span class="new">angiostatic steroids</span></li>
<li><a href="Heparin.htm" tppabs="https://ptable.com/wiki/compounds/A/Heparin" title="Heparin">heparin</a></li>
<li>angiostatin</li>
<li>bevacizumab</li>
<li>carboxyamidotriazole</li>
<li>Cartilage-Derived Angiogenesis Inhibitory Factor</li>
<li><span class="new">CM101</span></li>
<li>endostatin</li>
<li>IFN-α</li>
<li>IL-12</li>
<li><a href="Itraconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Itraconazole" title="Itraconazole">itraconazole</a></li>
<li><span class="new">linomide</span></li>
<li><a href="Matrix_metalloproteinase_inhibitor.htm" tppabs="https://ptable.com/wiki/compounds/A/Matrix_metalloproteinase_inhibitor" title="Matrix metalloproteinase inhibitor">matrix metalloproteinase inhibitors</a></li>
<li>platelet factor-4</li>
<li>prolactin</li>
<li>SU5416</li>
<li><a href="Suramin.htm" tppabs="https://ptable.com/wiki/compounds/A/Suramin" title="Suramin">suramin</a></li>
<li>tasquinimod</li>
<li><span class="new">tecogalan</span></li>
<li>tetrathiomolybdate</li>
<li><a href="Thalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Thalidomide" title="Thalidomide">thalidomide</a></li>
<li>thrombospondin</li>
<li>thrombospondin</li>
<li><span class="new">TNP-470</span></li>
<li>VEGFR antagonists</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">See also</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Angiogenesis</li>
<li>Angiogenesis inhibitors</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Immunosuppressive_drugs_/_Immunosuppressants_(L04)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Immunosuppressive_drugs_/_Immunosuppressants_(L04)" style="font-size:114%;margin:0 4em">Immunosuppressive drugs<span>&nbsp;</span>/ Immunosuppressants (L04)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Intracellular<br>(initiation)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Antimetabolites</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>purine synthesis inhibitors</i>
<ul><li><a href="Azathioprine.htm" tppabs="https://ptable.com/wiki/compounds/A/Azathioprine" title="Azathioprine">Azathioprine</a></li>
<li><a href="Mycophenolic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Mycophenolic_acid" title="Mycophenolic acid">Mycophenolic acid</a></li></ul></li></ul>

<ul><li><i>pyrimidine synthesis inhibitors</i>
<ul><li><a href="Leflunomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Leflunomide" title="Leflunomide">Leflunomide</a></li>
<li>Teriflunomide</li></ul></li></ul>

<ul><li><i>antifolate</i>
<ul><li><a href="Methotrexate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methotrexate" title="Methotrexate">Methotrexate</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Macrolides/<br>other <a href="Interleukin_2.htm" tppabs="https://ptable.com/wiki/compounds/A/Interleukin_2" title="Interleukin 2">IL-2</a> inhibitors</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>FKBP/Cyclophilin/Calcineurin</i>
<ul><li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li>
<li><a href="Ciclosporin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ciclosporin" title="Ciclosporin">Ciclosporin</a></li>
<li><a href="Pimecrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Pimecrolimus" title="Pimecrolimus">Pimecrolimus</a></li></ul></li></ul>

<ul><li>Abetimus</li>
<li>Gusperimus</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">IMiDs</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Lenalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Lenalidomide" title="Lenalidomide">Lenalidomide</a></li>
<li>Pomalidomide</li>
<li><a href="Thalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Thalidomide" title="Thalidomide">Thalidomide</a></li>
<li><i>PDE4 inhibitor</i>
<ul><li>Apremilast</li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Intracellular<br>(reception)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">IL-1 receptor antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Anakinra.htm" tppabs="https://ptable.com/wiki/compounds/A/Anakinra" title="Anakinra">Anakinra</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">mTOR</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Sirolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Sirolimus" title="Sirolimus">Sirolimus</a></li>
<li><a href="Everolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Everolimus" title="Everolimus">Everolimus</a></li>
<li>Ridaforolimus</li>
<li><a href="Temsirolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Temsirolimus" title="Temsirolimus">Temsirolimus</a></li>
<li>Umirolimus</li>
<li>Zotarolimus</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Extracellular</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Antibody.htm" tppabs="https://ptable.com/wiki/compounds/A/Antibody" title="Antibody">Antibodies</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Monoclonal</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Serum target<br>(noncellular)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Complement component 5</i>
<ul><li>Eculizumab</li></ul></li>
<li><i>TNF</i>
<ul><li><a href="Adalimumab.htm" tppabs="https://ptable.com/wiki/compounds/A/Adalimumab" title="Adalimumab">Adalimumab</a></li>
<li>Afelimomab</li>
<li>Certolizumab pegol</li>
<li>Golimumab</li>
<li><a href="Infliximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Infliximab" title="Infliximab">Infliximab</a></li>
<li>Nerelimomab</li></ul></li>
<li><i>Interleukin 5</i>
<ul><li>Mepolizumab</li></ul></li>
<li><i>Immunoglobulin E</i>
<ul><li><a href="Omalizumab.htm" tppabs="https://ptable.com/wiki/compounds/A/Omalizumab" title="Omalizumab">Omalizumab</a></li></ul></li></ul>

<ul><li><i>Interferon</i>
<ul><li>Faralimomab</li></ul></li></ul>

<ul><li><i>IL-6</i>
<ul><li>Elsilimomab</li></ul></li></ul>

<ul><li><i>IL-12 and IL-23</i>
<ul><li>Lebrikizumab</li>
<li>Ustekinumab</li></ul></li></ul>

<ul><li><i>IL-17A</i>
<ul><li>Secukinumab</li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cellular<br>target</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>CD3</i>
<ul><li><a href="Muromonab-CD3.htm" tppabs="https://ptable.com/wiki/compounds/A/Muromonab-CD3" title="Muromonab-CD3">Muromonab-CD3</a></li>
<li>Otelixizumab</li>
<li>Teplizumab</li>
<li>Visilizumab</li></ul></li>
<li><i>CD4</i>
<ul><li>Clenoliximab</li>
<li>Keliximab</li>
<li>Zanolimumab</li></ul></li>
<li><i>CD11a</i>
<ul><li>Efalizumab</li></ul></li>
<li><i>CD18</i>
<ul><li>Erlizumab</li></ul></li>
<li><i>CD20</i>
<ul><li>Obinutuzumab</li>
<li><a href="Rituximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Rituximab" title="Rituximab">Rituximab</a></li>
<li>Ocrelizumab</li>
<li>Pascolizumab</li></ul></li>
<li><i>CD23</i>
<ul><li>Gomiliximab</li>
<li>Lumiliximab</li></ul></li>
<li><i>CD40</i>
<ul><li>Teneliximab</li>
<li>Toralizumab</li></ul></li>
<li><i>CD62L/L-selectin</i>
<ul><li>Aselizumab</li></ul></li>
<li><i>CD80</i>
<ul><li>Galiximab</li></ul></li>
<li><i>CD147/Basigin</i>
<ul><li>Gavilimomab</li></ul></li>
<li><i>CD154</i>
<ul><li>Ruplizumab</li></ul></li></ul>

<ul><li><i>BLyS</i>
<ul><li>Belimumab</li>
<li>Blisibimod</li></ul></li>
<li><i>CTLA-4</i>
<ul><li>Ipilimumab</li>
<li>Tremelimumab</li></ul></li>
<li><i>CAT</i>
<ul><li>Bertilimumab</li>
<li>Lerdelimumab</li>
<li>Metelimumab</li></ul></li>
<li><i>Integrin</i>
<ul><li>Natalizumab</li>
<li>Vedolizumab</li></ul></li>
<li><i>Interleukin-6 receptor</i>
<ul><li>Tocilizumab</li></ul></li>
<li><i>LFA-1</i>
<ul><li>Odulimomab</li></ul></li></ul>

<ul><li><i>IL-2 receptor/CD25</i>
<ul><li><a href="Basiliximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Basiliximab" title="Basiliximab">Basiliximab</a></li>
<li><a href="Daclizumab.htm" tppabs="https://ptable.com/wiki/compounds/A/Daclizumab" title="Daclizumab">Daclizumab</a></li>
<li>Inolimomab</li></ul></li></ul>

<ul><li><i>T-lymphocyte</i> (Zolimomab aritox)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Unsorted</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Atorolimumab</li>
<li>Cedelizumab</li>
<li>Fontolizumab</li>
<li>Maslimomab</li>
<li>Morolimumab</li>
<li>Pexelizumab</li>
<li>Reslizumab</li>
<li>Rovelizumab</li>
<li>Siplizumab</li>
<li>Talizumab</li>
<li>Telimomab aritox</li>
<li>Vapaliximab</li>
<li>Vepalimomab</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Polyclonal</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Anti-thymocyte globulin</li>
<li>Anti-lymphocyte globulin</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">-cept (Fusion)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>CTLA-4</i>
<ul><li>Abatacept</li>
<li>Belatacept</li></ul></li>
<li><i>TNF inhibitor</i>
<ul><li><a href="Etanercept.htm" tppabs="https://ptable.com/wiki/compounds/A/Etanercept" title="Etanercept">Etanercept</a></li>
<li>Pegsunercept</li></ul></li>
<li>Aflibercept</li>
<li><a href="Alefacept.htm" tppabs="https://ptable.com/wiki/compounds/A/Alefacept" title="Alefacept">Alefacept</a></li>
<li>Rilonacept</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Androgen_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Androgen_receptor_modulators" style="font-size:114%;margin:0 4em">Androgen receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>AR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Testosterone derivatives:</i> <a href="4-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenediol" title="4-Androstenediol">4-Androstenediol</a></li>
<li>4-Dehydroepiandrosterone (4-DHEA)</li>
<li>4-Hydroxytestosterone</li>
<li><span class="new">4,17α-Dimethyltestosterone</span></li>
<li>5-Androstenedione</li>
<li>11-Ketotestosterone</li>
<li>11β-Hydroxyandrostenedione</li>
<li><a href="Adrenosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Adrenosterone" title="Adrenosterone">Adrenosterone (11-ketoandrostenedione, 11-oxoandrostenedione)</a></li>
<li><a href="5-Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Androstenediol" title="5-Androstenediol" class="mw-redirect">Androstenediol (5-androstenediol)</a>
<ul><li>Androstenediol 3β-acetate</li>
<li>Androstenediol 17β-acetate</li>
<li>Androstenediol diacetate</li>
<li>Androstenediol dipropionate</li></ul></li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/4-Androstenedione" title="4-Androstenedione" class="mw-redirect">Androstenedione (4-androstenedione)</a></li>
<li>Atamestane</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Boldenone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Boldenone'" tppabs="https://ptable.com/wiki/compounds/A/Boldenone" title="Boldenone">Boldenone</a>
<ul><li>Boldenone undecylenate</li></ul></li>
<li>Boldione (1,4-androstadienedione)</li>
<li><a href="Clostebol.htm" tppabs="https://ptable.com/wiki/compounds/A/Clostebol" title="Clostebol">Clostebol</a>
<ul><li>Clostebol acetate</li>
<li>Clostebol caproate</li>
<li>Clostebol propionate</li></ul></li>
<li>Cloxotestosterone
<ul><li>Cloxotestosterone acetate</li></ul></li>
<li>Dehydroandrosterone</li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA (androstenolone, prasterone; 5-DHEA)</a>
<ul><li>DHEA enanthate (prasterone enanthate)</li>
<li><a href="Dehydroepiandrosterone_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">DHEA sulfate</a></li></ul></li>
<li><a href="Exemestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Exemestane" title="Exemestane">Exemestane</a></li>
<li><a href="Formestane.htm" tppabs="https://ptable.com/wiki/compounds/A/Formestane" title="Formestane">Formestane</a></li>
<li>Plomestane</li>
<li>Quinbolone</li>
<li>Silandrone</li>
<li>Testosterone<sup>#</sup> (+dutasteride)
<ul><li>Testosterone esters</li>
<li>Polytestosterone phloretin phosphate</li></ul></li></ul>

<ul><li><i>5α-Dihydrotestosterone derivatives:</i> 1-Androstenediol</li>
<li>1-Androstenedione</li>
<li>1-Androsterone (1-andro, 1-DHEA)</li>
<li>1-Testosterone</li>
<li>3α-Androstanediol</li>
<li>5α-Androst-2-en-17-one</li>
<li>7β-Hydroxyepiandrosterone</li>
<li>11-Ketodihydrotestosterone</li>
<li><a href="Androsterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Androsterone" title="Androsterone">Androsterone</a></li>
<li>Bolazine
<ul><li>Bolazine capronate</li></ul></li>
<li><span class="new">Dihydroethyltestosterone</span></li>
<li>Dihydrofluoxymesterone</li>
<li><span class="new">Dihydromethylandrostenediol</span></li>
<li><a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">Dihydrotestosterone (DHT)</a> (androstanolone, stanolone)
<ul><li>Dihydrotestosterone esters</li></ul></li>
<li><a href="Drostanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drostanolone" title="Drostanolone">Drostanolone</a>
<ul><li>Drostanolone propionate</li></ul></li>
<li><a href="Epiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Epiandrosterone" title="Epiandrosterone">Epiandrosterone</a></li>
<li>Epitiostanol</li>
<li>Mepitiostane</li>
<li>Mesabolone</li>
<li><a href="Mesterolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mesterolone" title="Mesterolone">Mesterolone</a>
<ul><li>Mesterolone cipionate</li></ul></li>
<li>Methyldiazinol</li>
<li>Nisterime
<ul><li>Nisterime acetate</li></ul></li>
<li>Prostanozol</li>
<li>Stenbolone
<ul><li>Stenbolone acetate</li></ul></li>
<li>Testifenon (testiphenon, testiphenone)</li></ul>

<ul><li><i>19-Nortestosterone derivatives:</i> 7α-Methyl-19-norandrostenedione (MENT dione, trestione)</li>
<li>11β-Methyl-19-nortestosterone
<ul><li>11β-Methyl-19-nortestosterone dodecylcarbonate</li></ul></li>
<li>19-Nor-5-androstenediol</li>
<li>19-Nor-5-androstenedione</li>
<li>19-Nordehydroepiandrosterone</li>
<li>Bolandiol
<ul><li>Bolandiol dipropionate</li></ul></li>
<li>Bolandione (19-nor-4-androstenedione)</li>
<li>Bolmantalate (nandrolone adamantoate)</li>
<li>Dienedione</li>
<li>Dienolone</li>
<li>Dimethandrolone
<ul><li>Dimethandrolone buciclate</li>
<li>Dimethandrolone dodecylcarbonate</li>
<li>Dimethandrolone undecanoate</li></ul></li>
<li>LS-1727 (nandrolone 17β-<i>N</i>-(2-chloroethyl)-<i>N</i>-nitrosocarbamate)</li>
<li>Methoxydienone (methoxygonadiene)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">Nandrolone</a>
<ul><li>Nandrolone esters</li></ul></li>
<li>Norclostebol
<ul><li>Norclostebol acetate</li></ul></li>
<li>Normethandrone (methylestrenolone, normethisterone)</li>
<li><a href="Oxabolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxabolone" title="Oxabolone">Oxabolone</a>
<ul><li><a href="Oxabolone_cipionate.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxabolone_cipionate" title="Oxabolone cipionate">Oxabolone cipionate (oxabolone cypionate)</a></li></ul></li>
<li>Trenbolone
<ul><li>Trenbolone acetate</li>
<li>Trenbolone enanthate</li>
<li>Trenbolone hexahydrobenzylcarbonate</li>
<li>Trenbolone undecanoate</li></ul></li>
<li>Trendione</li>
<li>Trestolone (MENT)
<ul><li>Trestolone acetate</li>
<li>Trestolone enanthate</li></ul></li></ul>

<ul><li><i>5α-Dihydro-19-nortestosterone derivatives:</i> 5α-Dihydronandrolone</li>
<li><span class="new">5α-Dihydrotrestolone</span></li>
<li>19-Norandrosterone</li></ul>

<ul><li><i>17α-Alkylated testosterone derivatives:</i> <a href="Bolasterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Bolasterone" title="Bolasterone">Bolasterone</a></li>
<li><a href="Calusterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Calusterone" title="Calusterone">Calusterone</a></li>
<li>Chlorodehydromethylandrostenediol (CDMA)</li>
<li>Chlorodehydromethyltestosterone (CDMT)</li>
<li>Chloromethylandrostenediol (CMA)</li>
<li>Enestebol</li>
<li>Ethyltestosterone</li>
<li><a href="Fluoxymesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluoxymesterone" title="Fluoxymesterone">Fluoxymesterone</a></li>
<li><a href="Formebolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Formebolone" title="Formebolone">Formebolone</a></li>
<li>Hydroxystenozole</li>
<li>Metandienone (methandrostenolone)</li>
<li>Methandriol (methylandrostenediol)
<ul><li>Methandriol bisenanthoyl acetate</li>
<li>Methandriol diacetate</li>
<li>Methandriol dipropionate</li>
<li>Methandriol propionate</li></ul></li>
<li>Methylclostebol (chloromethyltestosterone)</li>
<li><a href="Methyltestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyltestosterone" title="Methyltestosterone">Methyltestosterone</a> (+esterified estrogens)
<ul><li>Methyltestosterone 3-hexyl ether</li></ul></li>
<li>Oxymesterone</li>
<li>Penmesterol</li>
<li>Tiomesterone</li></ul>

<ul><li><i>17α-Alkylated 5α-dihydrotestosterone derivatives:</i> Androisoxazole</li>
<li>Desoxymethyltestosterone</li>
<li><a href="Furazabol.htm" tppabs="https://ptable.com/wiki/compounds/A/Furazabol" title="Furazabol">Furazabol</a></li>
<li>Mebolazine (dimethazine)</li>
<li><a href="Mestanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mestanolone" title="Mestanolone">Mestanolone</a></li>
<li>Metenolone
<ul><li>Metenolone acetate</li>
<li>Metenolone enanthate</li></ul></li>
<li>Methasterone</li>
<li>Methyl-1-testosterone</li>
<li>Methylepitiostanol</li>
<li>Methylstenbolone</li>
<li><a href="Oxandrolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxandrolone" title="Oxandrolone">Oxandrolone</a></li>
<li><a href="Oxymetholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxymetholone" title="Oxymetholone">Oxymetholone</a></li>
<li><a href="Stanozolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Stanozolol" title="Stanozolol">Stanozolol</a></li></ul>

<ul><li><i>17α-Alkylated 19-nortestosterone derivatives:</i> Bolenol</li>
<li>Dimethyldienolone</li>
<li>Dimethyltrienolone</li>
<li>Ethyldienolone</li>
<li><a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">Ethylestrenol</a></li>
<li>Methyldienolone</li>
<li>Methylhydroxynandrolone (MOHN, MHN)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">Metribolone</a></li>
<li>Mibolerone</li>
<li>Norboletone</li>
<li>Norethandrolone</li>
<li>Propetandrol</li>
<li>RU-2309</li>
<li>Tetrahydrogestrinone</li></ul>

<ul><li><i>17α-Alkylated 5α-dihydro-19-nortestosterone derivatives:</i> 5α-Dihydronorethandrolone</li>
<li>5α-Dihydronormethandrone</li></ul>

<ul><li><i>17α-Vinyltestosterone derivatives:</i> Norvinisterone (vinylnortestosterone)</li></ul>

<ul><li><i>17α-Vinyl-19-nortestosterone derivatives:</i> Vinyltestosterone</li></ul>

<ul><li><i>17α-Ethynyltestosterone derivatives:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li>Ethinylandrostenediol
<ul><li>Ethandrostate</li></ul></li>
<li><a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">Ethisterone (ethynyltestosterone)</a></li></ul>

<ul><li><i>5α-Dihydro-17α-ethynyltestosterone derivatives:</i> 17α-Ethynyl-3α-androstanediol</li>
<li>17α-Ethynyl-3β-androstanediol</li>
<li>Dihydroethisterone</li></ul>

<ul><li><i>17α-Ethynyl-19-nortestosterone derivatives:</i> Δ<sup>4</sup>-Tibolone</li>
<li><a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">Desogestrel</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Etonogestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Etonogestrel'" tppabs="https://ptable.com/wiki/compounds/A/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li>
<li>Etynodiol
<ul><li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li></ul></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a></li>
<li>Levonorgestrel esters (e.g., levonorgestrel butanoate)</li>
<li>Lynestrenol
<ul><li>Lynestrenol phenylpropionate</li></ul></li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone</a></li>
<li>Norethisterone esters (e.g., norethisterone acetate, norethisterone enanthate)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a></li>
<li>Norgestrienone</li>
<li>Quingestanol
<ul><li>Quingestanol acetate</li></ul></li>
<li>Tibolone</li></ul>

<ul><li><i>5α-Dihydro-17α-ethynyl-19-nortestosterone derivatives:</i> 5α-Dihydrolevonorgestrel</li>
<li>5α-Dihydronorethisterone</li></ul>

<ul><li><i>Progesterone derivatives:</i> 6α-Methylprogesterone</li>
<li><a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li>
<li>Megestrol acetate</li></ul>

<ul><li><i>Others/unsorted:</i> 3-Keto-5α-abiraterone</li>
<li><a href="Androstane.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Androstane" title="5α-Androstane" class="mw-redirect">5α-Androstane</a></li>
<li>Alternariol</li>
<li>Cl-4AS-1</li>
<li>Drupanol</li>
<li><a href="Trilostane.htm" tppabs="https://ptable.com/wiki/compounds/A/Trilostane" title="Trilostane">Trilostane</a></li>
<li>ZM-182345</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br>(<abbr>SARMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nonsteroidal:</i> <span class="new">198RL26</span></li>
<li><span class="new">ACP-105</span></li>
<li><span class="new">AC-262536</span></li>
<li>Acetothiolutamide</li>
<li>Andarine (acetamidoxolutamide, androxolutamide, GTx-007, S-4)</li>
<li><span class="new">BMS-564929</span></li>
<li><span class="new">DTIB</span></li>
<li>Enobosarm (ostarine, MK-2866, GTx-024, S-22)</li>
<li><span class="new">FTBU-1</span></li>
<li>GSK2881078</li>
<li><span class="new">GSK-4336A</span></li>
<li><span class="new">GSK-8698</span></li>
<li>LG-121071 (LGD-121071)</li>
<li>LGD-2226</li>
<li><span class="new">LGD-2941 (LGD-122941)</span></li>
<li>LGD-3303</li>
<li>LGD-4033</li>
<li>LY-2452473</li>
<li><span class="new">JNJ-26146900</span></li>
<li>JNJ-28330835</li>
<li><span class="new">JNJ-37654032</span></li>
<li><span class="new">ORM-11984</span></li>
<li><span class="new">R-1</span></li>
<li>RAD140</li>
<li>RU-59063</li>
<li><span class="new">S-1</span></li>
<li>S-23</li>
<li>S-40503</li>
<li><span class="new">S-101479</span></li>
<li>Triclosan</li></ul>

<ul><li><i>Steroidal:</i> <span class="new">EM-9017</span></li>
<li>MK-0773</li>
<li>TFM-4AS-1</li>
<li>YK-11</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> 7α-Thioprogesterone</li>
<li>7α-Thiospironolactone</li>
<li>7α-Thiomethylspironolactone</li>
<li>11α-Hydroxyprogesterone</li>
<li>15β-Hydroxycyproterone acetate</li>
<li>Abiraterone</li>
<li>Abiraterone acetate</li>
<li>Allyltestosterone</li>
<li>Benorterone</li>
<li>BOMT</li>
<li>Canrenoic acid</li>
<li>Canrenone</li>
<li>Chlormadinone acetate</li>
<li>Clascoterone</li>
<li>Clometerone</li>
<li><a href="Cyproheptadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproheptadine" title="Cyproheptadine">Cyproheptadine</a></li>
<li><a href="Cyproterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyproterone" title="Cyproterone">Cyproterone</a></li>
<li>Cyproterone acetate</li>
<li>Delanterone</li>
<li>Delmadinone acetate</li>
<li>Dicirenone</li>
<li>Dienogest</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li>DU-41165</li>
<li>Edogestrone</li>
<li><span class="new">EM-4350</span></li>
<li>EM-5854</li>
<li><span class="new">EM-5855</span></li>
<li><span class="new">EM-6537</span></li>
<li>Epitestosterone</li>
<li>Galeterone</li>
<li>Guggulsterone</li>
<li>Medrogestone</li>
<li>Megestrol acetate</li>
<li>Mespirenone</li>
<li>Metogest</li>
<li>Mexrenone</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li>Nomegestrol acetate</li>
<li>Nordinone</li>
<li>Osaterone</li>
<li>Osaterone acetate</li>
<li>Oxendolone</li>
<li>Potassium canrenoate</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">Promegestone</a></li>
<li>Prorenone</li>
<li>Rosterolone</li>
<li><span class="new">RU-15328</span></li>
<li>SC-5233 (spirolactone)</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spirorenone</li>
<li>Spiroxasone</li>
<li>Topterone</li>
<li>Trimegestone</li>
<li>Trimethyltrienolone (R-2956)</li>
<li>Zanoterone</li></ul>

<ul><li><i>Nonsteroidal:</i> 5<i>N</i>-Bicalutamide</li>
<li>AA560</li>
<li><span class="new">Antarlides</span></li>
<li><span class="new">Arabilin</span></li>
<li>Apalutamide</li>
<li>Atraric acid</li>
<li><span class="new">AZD-3514</span></li>
<li>Bakuchiol</li>
<li><span class="new">BAY-1024767</span></li>
<li><a href="Bicalutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Bicalutamide" title="Bicalutamide">Bicalutamide</a></li>
<li><a href="Bisphenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol" title="Bisphenol">Bisphenols</a> (e.g., <a href="Bisphenol_A_diglycidyl_ether.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A_diglycidyl_ether" title="Bisphenol A diglycidyl ether">BADGE</a>, <span class="new">BFDGE</span>, <a href="Bisphenol_A.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_A" title="Bisphenol A">bisphenol A</a>, bisphenol F, <a href="Bisphenol_S.htm" tppabs="https://ptable.com/wiki/compounds/A/Bisphenol_S" title="Bisphenol S">bisphenol S</a>)</li>
<li><span class="new">BMS-501949</span></li>
<li><span class="new">BMS-570511</span></li>
<li>BMS-641988</li>
<li><span class="new">CH5137291</span></li>
<li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a></li>
<li>Cioteronel</li>
<li>Cyanonilutamide</li>
<li>Darolutamide</li>
<li>DDT (via metabolite p,p’-DDE)</li>
<li><a href="Dieldrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dieldrin" title="Dieldrin">Dieldrin</a></li>
<li>DIMP</li>
<li><a href="Endosulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Endosulfan" title="Endosulfan">Endosulfan</a></li>
<li>Enzalutamide</li>
<li>EPI-001</li>
<li>EPI-7386</li>
<li><a href="Fenarimol.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenarimol" title="Fenarimol">Fenarimol</a></li>
<li><a href="Flutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Flutamide" title="Flutamide">Flutamide</a></li>
<li>Hydroxyflutamide</li>
<li>Inocoterone</li>
<li>Inocoterone acetate</li>
<li><a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li>Ketodarolutamide</li>
<li>Lavender oil</li>
<li><span class="new">LG-105</span></li>
<li>LG-120907</li>
<li><span class="new">LGD-1331</span></li>
<li>Linuron</li>
<li><a href="Methiocarb.htm" tppabs="https://ptable.com/wiki/compounds/A/Methiocarb" title="Methiocarb">Methiocarb</a></li>
<li><span class="new"><i>N</i>-Butylbenzenesulfonamide</span></li>
<li><i>N</i>-Desmethylapalutamide</li>
<li><i>N</i>-Desmethylenzalutamide</li>
<li><a href="Nilutamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nilutamide" title="Nilutamide">Nilutamide</a></li>
<li><span class="new">ONC1-13B</span></li>
<li>Pentomone</li>
<li><span class="new">PF-998425</span></li>
<li><a href="Phenothrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenothrin" title="Phenothrin">Phenothrin</a></li>
<li>Prochloraz</li>
<li><a href="Procymidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Procymidone" title="Procymidone">Procymidone</a></li>
<li>Proxalutamide</li>
<li>Ralaniten (EPI-002)</li>
<li>Ralaniten acetate (EPI-506)</li>
<li>RD-162</li>
<li><span class="new">Ro 2-7239</span></li>
<li><span class="new">Ro 5-2537</span></li>
<li>RU-22930</li>
<li>RU-56187</li>
<li>RU-57073</li>
<li>RU-58642</li>
<li>RU-58841</li>
<li>Seviteronel</li>
<li><a href="Thalidomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Thalidomide" title="Thalidomide">Thalidomide</a></li>
<li>Topilutamide (fluridil)</li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li>
<li>Vinclozolin</li>
<li><span class="new">YM-580</span></li>
<li><span class="new">YM-92088</span></li>
<li><span class="new">YM-175735</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>GPRC6A</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center;">Agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cations (incl. aluminum, <a href="Calcium.htm" tppabs="https://ptable.com/wiki/compounds/A/Calcium" title="Calcium">calcium</a>, <a href="Gadolinium.htm" tppabs="https://ptable.com/wiki/compounds/A/Gadolinium" title="Gadolinium">gadolinium</a>, <a href="Magnesium.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium" title="Magnesium">magnesium</a>, <a href="Strontium.htm" tppabs="https://ptable.com/wiki/compounds/A/Strontium" title="Strontium">strontium</a>, <a href="Zinc.htm" tppabs="https://ptable.com/wiki/compounds/A/Zinc" title="Zinc">zinc</a>)</li>
<li>Dehydroandrosterone</li>
<li><a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">Dihydrotestosterone</a></li>
<li><a href="Estradiol.htm" tppabs="https://ptable.com/wiki/compounds/A/Estradiol" title="Estradiol">Estradiol</a></li>
<li><small>L</small>-α-Amino acids (incl. <a href="Arginine.htm" tppabs="https://ptable.com/wiki/compounds/A/Arginine" title="Arginine"><small>L</small>-arginine</a>, <a href="Lysine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lysine" title="Lysine"><small>L</small>-lysine</a>, <a href="Ornithine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ornithine" title="Ornithine"><small>L</small>-ornithine</a>)</li>
<li>Osteocalcin</li>
<li><abbr>SHBG</abbr></li>
<li><a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">Testosterone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Estrogen receptor modulators</dd>
<dd>Progesterone receptor modulators</dd>
<dd>List of androgens/anabolic steroids</dd></dl>
</div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox authority-control" aria-labelledby="Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q203174&amp;#124;Edit_this_at_Wikidata" style="padding:3px"><table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th id="Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q203174&amp;#124;Edit_this_at_Wikidata" scope="row" class="navbox-group" style="width:1%">Authority control <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="nowrap">GND: <span class="uid"><a href="javascript:if(confirm('https://d-nb.info/gnd/4184973-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://d-nb.info/gnd/4184973-5'" tppabs="https://d-nb.info/gnd/4184973-5" class="external text external">4184973-5</a></span></span></li>
<li><span class="nowrap">NDL: <span class="uid"><a href="javascript:if(confirm('https://id.ndl.go.jp/auth/ndlna/00570209  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://id.ndl.go.jp/auth/ndlna/00570209'" tppabs="https://id.ndl.go.jp/auth/ndlna/00570209" class="external text external">00570209</a></span></span></li></ul>

</div></td></tr></tbody></table></div>




















<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>